2D miR_HR1_12
Gene Symbol | Gene ID | Gene Info |
---|---|---|
Spi1
|
ENSMUSG00000002111.8 | spleen focus forming virus (SFFV) proviral integration oncogene |
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
Spi1 | mm10_v2_chr2_+_91082362_91082390 | 0.64 | 2.6e-02 | Click! |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr15_+_78244781 | 3.42 |
ENSMUST00000096357.5
ENSMUST00000133618.1 |
Ncf4
|
neutrophil cytosolic factor 4 |
chr3_-_90695706 | 3.28 |
ENSMUST00000069960.5
ENSMUST00000117167.1 |
S100a9
|
S100 calcium binding protein A9 (calgranulin B) |
chr11_-_83592981 | 2.48 |
ENSMUST00000019071.3
|
Ccl6
|
chemokine (C-C motif) ligand 6 |
chr14_+_103046977 | 2.38 |
ENSMUST00000022722.6
|
Irg1
|
immunoresponsive gene 1 |
chr7_-_45239108 | 2.34 |
ENSMUST00000033063.6
|
Cd37
|
CD37 antigen |
chr3_+_90669063 | 2.08 |
ENSMUST00000069927.8
|
S100a8
|
S100 calcium binding protein A8 (calgranulin A) |
chr11_-_83578496 | 1.96 |
ENSMUST00000019266.5
|
Ccl9
|
chemokine (C-C motif) ligand 9 |
chr7_-_127137807 | 1.79 |
ENSMUST00000049931.5
|
Spn
|
sialophorin |
chr2_+_19445632 | 1.77 |
ENSMUST00000028068.2
|
Ptf1a
|
pancreas specific transcription factor, 1a |
chr6_+_70726430 | 1.71 |
ENSMUST00000103410.1
|
Igkc
|
immunoglobulin kappa constant |
chr7_-_127218390 | 1.71 |
ENSMUST00000142356.1
ENSMUST00000106314.1 |
Sept1
|
septin 1 |
chr7_-_45239041 | 1.68 |
ENSMUST00000131290.1
|
Cd37
|
CD37 antigen |
chrX_-_108664891 | 1.65 |
ENSMUST00000178160.1
|
Gm379
|
predicted gene 379 |
chr8_+_105427634 | 1.63 |
ENSMUST00000067305.6
|
Lrrc36
|
leucine rich repeat containing 36 |
chr5_+_90786100 | 1.62 |
ENSMUST00000031326.8
|
Cxcl3
|
chemokine (C-X-C motif) ligand 3 |
chr11_-_115133981 | 1.61 |
ENSMUST00000106561.1
ENSMUST00000051264.7 ENSMUST00000106562.2 |
Cd300lf
|
CD300 antigen like family member F |
chr13_-_23622502 | 1.61 |
ENSMUST00000062045.2
|
Hist1h1e
|
histone cluster 1, H1e |
chr9_-_123968683 | 1.58 |
ENSMUST00000026911.4
|
Ccr1
|
chemokine (C-C motif) receptor 1 |
chr11_+_70130329 | 1.44 |
ENSMUST00000041550.5
ENSMUST00000165951.1 |
Mgl2
|
macrophage galactose N-acetyl-galactosamine specific lectin 2 |
chr5_-_123865491 | 1.37 |
ENSMUST00000057145.5
|
Niacr1
|
niacin receptor 1 |
chr2_-_25196759 | 1.36 |
ENSMUST00000081869.6
|
Tor4a
|
torsin family 4, member A |
chr17_-_27728889 | 1.36 |
ENSMUST00000167489.1
ENSMUST00000138970.1 ENSMUST00000114870.1 ENSMUST00000025054.2 |
Spdef
|
SAM pointed domain containing ets transcription factor |
chr6_-_123289862 | 1.33 |
ENSMUST00000032239.4
ENSMUST00000177367.1 |
Clec4e
|
C-type lectin domain family 4, member e |
chr14_-_8378753 | 1.29 |
ENSMUST00000022269.5
|
Oit1
|
oncoprotein induced transcript 1 |
chr5_-_135573036 | 1.27 |
ENSMUST00000004936.6
|
Ccl24
|
chemokine (C-C motif) ligand 24 |
chr1_-_173333503 | 1.23 |
ENSMUST00000038227.4
|
Darc
|
Duffy blood group, chemokine receptor |
chr4_+_54947976 | 1.19 |
ENSMUST00000098070.3
|
Zfp462
|
zinc finger protein 462 |
chr12_-_113422730 | 1.18 |
ENSMUST00000177715.1
ENSMUST00000103426.1 |
Ighm
|
immunoglobulin heavy constant mu |
chr2_+_91096744 | 1.17 |
ENSMUST00000132741.2
|
Spi1
|
spleen focus forming virus (SFFV) proviral integration oncogene |
chr6_-_124738714 | 1.16 |
ENSMUST00000171549.2
|
Ptpn6
|
protein tyrosine phosphatase, non-receptor type 6 |
chr6_-_124738579 | 1.16 |
ENSMUST00000174265.1
ENSMUST00000004377.8 |
Ptpn6
|
protein tyrosine phosphatase, non-receptor type 6 |
chrX_+_164162167 | 1.15 |
ENSMUST00000131543.1
|
Ace2
|
angiotensin I converting enzyme (peptidyl-dipeptidase A) 2 |
chr17_-_35201996 | 1.14 |
ENSMUST00000167924.1
ENSMUST00000025263.8 |
Tnf
|
tumor necrosis factor |
chr18_-_36726730 | 1.13 |
ENSMUST00000061829.6
|
Cd14
|
CD14 antigen |
chr3_+_87357874 | 1.13 |
ENSMUST00000015998.6
|
Cd5l
|
CD5 antigen-like |
chr7_+_142460834 | 1.11 |
ENSMUST00000018963.4
ENSMUST00000105967.1 |
Lsp1
|
lymphocyte specific 1 |
chr9_+_21526144 | 1.10 |
ENSMUST00000086361.5
ENSMUST00000179459.1 ENSMUST00000173769.2 |
AB124611
|
cDNA sequence AB124611 |
chrX_+_164436987 | 1.09 |
ENSMUST00000036858.4
|
Asb11
|
ankyrin repeat and SOCS box-containing 11 |
chr9_-_88731850 | 1.09 |
ENSMUST00000098486.2
|
Bcl2a1d
|
B cell leukemia/lymphoma 2 related protein A1d |
chr3_+_138277489 | 1.08 |
ENSMUST00000004232.9
|
Adh1
|
alcohol dehydrogenase 1 (class I) |
chr7_-_46715676 | 1.06 |
ENSMUST00000006956.7
|
Saa3
|
serum amyloid A 3 |
chr11_+_82115180 | 1.05 |
ENSMUST00000009329.2
|
Ccl8
|
chemokine (C-C motif) ligand 8 |
chr13_-_37049203 | 1.04 |
ENSMUST00000037491.8
|
F13a1
|
coagulation factor XIII, A1 subunit |
chr11_+_83703991 | 1.04 |
ENSMUST00000092836.5
|
Wfdc17
|
WAP four-disulfide core domain 17 |
chr11_+_69964758 | 1.03 |
ENSMUST00000108597.1
ENSMUST00000060651.5 ENSMUST00000108596.1 |
Cldn7
|
claudin 7 |
chr7_-_19796789 | 1.03 |
ENSMUST00000108449.2
ENSMUST00000043822.7 |
Cblc
|
Casitas B-lineage lymphoma c |
chr1_+_172475358 | 1.03 |
ENSMUST00000027830.4
|
Slamf9
|
SLAM family member 9 |
chr16_-_42340595 | 1.03 |
ENSMUST00000102817.4
|
Gap43
|
growth associated protein 43 |
chr7_+_27195781 | 1.03 |
ENSMUST00000108379.1
ENSMUST00000179391.1 |
BC024978
|
cDNA sequence BC024978 |
chr12_+_36314160 | 1.01 |
ENSMUST00000041407.5
|
Sostdc1
|
sclerostin domain containing 1 |
chr2_-_24048857 | 1.00 |
ENSMUST00000114497.1
|
Hnmt
|
histamine N-methyltransferase |
chr5_-_29735928 | 1.00 |
ENSMUST00000065372.3
|
Gm5129
|
predicted gene 5129 |
chr9_+_110476985 | 0.99 |
ENSMUST00000084948.4
ENSMUST00000061155.6 ENSMUST00000140686.1 ENSMUST00000084952.5 |
Kif9
|
kinesin family member 9 |
chr11_+_61126747 | 0.99 |
ENSMUST00000010286.1
ENSMUST00000146033.1 ENSMUST00000139422.1 |
Tnfrsf13b
|
tumor necrosis factor receptor superfamily, member 13b |
chr17_-_48167187 | 0.98 |
ENSMUST00000053612.6
ENSMUST00000027764.8 |
A530064D06Rik
|
RIKEN cDNA A530064D06 gene |
chr10_+_127866457 | 0.97 |
ENSMUST00000092058.3
|
BC089597
|
cDNA sequence BC089597 |
chr11_+_34047115 | 0.97 |
ENSMUST00000109329.1
ENSMUST00000169878.2 |
Lcp2
|
lymphocyte cytosolic protein 2 |
chr7_-_3898120 | 0.97 |
ENSMUST00000070639.7
|
Gm14548
|
predicted gene 14548 |
chr7_-_45238794 | 0.95 |
ENSMUST00000098461.1
ENSMUST00000107797.1 |
Cd37
|
CD37 antigen |
chr2_+_70562007 | 0.95 |
ENSMUST00000094934.4
|
Gad1
|
glutamate decarboxylase 1 |
chr11_-_49113757 | 0.94 |
ENSMUST00000060398.1
|
Olfr1396
|
olfactory receptor 1396 |
chr10_-_83648713 | 0.94 |
ENSMUST00000020500.7
|
Appl2
|
adaptor protein, phosphotyrosine interaction, PH domain and leucine zipper containing 2 |
chr19_+_6164433 | 0.92 |
ENSMUST00000045042.7
|
Batf2
|
basic leucine zipper transcription factor, ATF-like 2 |
chr19_-_6921753 | 0.92 |
ENSMUST00000173635.1
|
Esrra
|
estrogen related receptor, alpha |
chr1_+_160044564 | 0.92 |
ENSMUST00000168359.1
|
4930523C07Rik
|
RIKEN cDNA 4930523C07 gene |
chr10_-_127041513 | 0.92 |
ENSMUST00000116231.2
|
Mettl21b
|
methyltransferase like 21B |
chr16_+_5007283 | 0.91 |
ENSMUST00000184439.1
|
Smim22
|
small integral membrane protein 22 |
chr10_+_127323700 | 0.91 |
ENSMUST00000069548.5
|
Arhgap9
|
Rho GTPase activating protein 9 |
chr8_-_38661508 | 0.91 |
ENSMUST00000118896.1
|
Sgcz
|
sarcoglycan zeta |
chr6_+_28981490 | 0.90 |
ENSMUST00000164104.1
|
Gm3294
|
predicted gene 3294 |
chr7_+_19083842 | 0.90 |
ENSMUST00000032568.7
ENSMUST00000122999.1 ENSMUST00000108473.3 ENSMUST00000108474.1 |
Dmpk
|
dystrophia myotonica-protein kinase |
chr1_-_138175283 | 0.89 |
ENSMUST00000182755.1
ENSMUST00000183262.1 ENSMUST00000027645.7 ENSMUST00000112036.2 ENSMUST00000182283.1 |
Ptprc
|
protein tyrosine phosphatase, receptor type, C |
chr2_+_69135799 | 0.89 |
ENSMUST00000041865.7
|
Nostrin
|
nitric oxide synthase trafficker |
chr7_+_142460809 | 0.87 |
ENSMUST00000105968.1
|
Lsp1
|
lymphocyte specific 1 |
chr5_+_21372642 | 0.87 |
ENSMUST00000035799.5
|
Fgl2
|
fibrinogen-like protein 2 |
chr3_+_89436699 | 0.87 |
ENSMUST00000038942.3
ENSMUST00000130858.1 |
Pbxip1
|
pre B cell leukemia transcription factor interacting protein 1 |
chr6_-_126166726 | 0.86 |
ENSMUST00000112244.2
ENSMUST00000050484.7 |
Ntf3
|
neurotrophin 3 |
chr11_-_69880971 | 0.86 |
ENSMUST00000050555.3
|
Kctd11
|
potassium channel tetramerisation domain containing 11 |
chr11_+_29692937 | 0.84 |
ENSMUST00000102843.3
ENSMUST00000102842.3 ENSMUST00000078830.4 ENSMUST00000170731.1 |
Rtn4
|
reticulon 4 |
chr1_+_151571481 | 0.82 |
ENSMUST00000111875.1
|
Fam129a
|
family with sequence similarity 129, member A |
chr13_-_55021287 | 0.82 |
ENSMUST00000148221.1
ENSMUST00000052949.6 |
Hk3
|
hexokinase 3 |
chr10_-_24101951 | 0.82 |
ENSMUST00000170267.1
|
Taar8c
|
trace amine-associated receptor 8C |
chr7_-_73537621 | 0.82 |
ENSMUST00000172704.1
|
Chd2
|
chromodomain helicase DNA binding protein 2 |
chr11_+_70166623 | 0.82 |
ENSMUST00000102571.3
ENSMUST00000178945.1 ENSMUST00000000327.6 |
Clec10a
|
C-type lectin domain family 10, member A |
chr9_-_48605147 | 0.81 |
ENSMUST00000034808.5
ENSMUST00000119426.1 |
Nnmt
|
nicotinamide N-methyltransferase |
chr11_+_87760533 | 0.81 |
ENSMUST00000039627.5
ENSMUST00000100644.3 |
Bzrap1
|
benzodiazepine receptor associated protein 1 |
chr10_-_10558199 | 0.81 |
ENSMUST00000019974.3
|
Rab32
|
RAB32, member RAS oncogene family |
chr1_+_152807877 | 0.81 |
ENSMUST00000027754.6
|
Ncf2
|
neutrophil cytosolic factor 2 |
chr11_+_95842668 | 0.81 |
ENSMUST00000100532.3
ENSMUST00000036088.4 |
Gngt2
|
guanine nucleotide binding protein (G protein), gamma transducing activity polypeptide 2 |
chr15_-_78572754 | 0.80 |
ENSMUST00000043214.6
|
Rac2
|
RAS-related C3 botulinum substrate 2 |
chr7_-_141100526 | 0.79 |
ENSMUST00000097958.2
|
Sigirr
|
single immunoglobulin and toll-interleukin 1 receptor (TIR) domain |
chr6_+_123262107 | 0.79 |
ENSMUST00000032240.2
|
Clec4d
|
C-type lectin domain family 4, member d |
chr1_+_91801453 | 0.79 |
ENSMUST00000007949.3
|
Twist2
|
twist basic helix-loop-helix transcription factor 2 |
chr11_-_109722214 | 0.79 |
ENSMUST00000020938.7
|
Fam20a
|
family with sequence similarity 20, member A |
chr11_+_98412461 | 0.79 |
ENSMUST00000058295.5
|
Erbb2
|
v-erb-b2 erythroblastic leukemia viral oncogene homolog 2, neuro/glioblastoma derived oncogene homolog (avian) |
chr3_-_106790143 | 0.78 |
ENSMUST00000038845.8
|
Cd53
|
CD53 antigen |
chr7_-_101864093 | 0.77 |
ENSMUST00000106981.1
|
Folr1
|
folate receptor 1 (adult) |
chr3_+_95526777 | 0.77 |
ENSMUST00000015667.2
ENSMUST00000116304.2 |
Ctss
|
cathepsin S |
chr10_-_29144194 | 0.77 |
ENSMUST00000070359.2
|
Gm9996
|
predicted gene 9996 |
chr11_+_95842283 | 0.76 |
ENSMUST00000107714.2
ENSMUST00000107711.1 |
Gngt2
|
guanine nucleotide binding protein (G protein), gamma transducing activity polypeptide 2 |
chr5_+_52190650 | 0.76 |
ENSMUST00000180601.1
|
9230114K14Rik
|
RIKEN cDNA 9230114K14 gene |
chr1_-_121327776 | 0.76 |
ENSMUST00000160688.1
|
Insig2
|
insulin induced gene 2 |
chrX_-_155623325 | 0.76 |
ENSMUST00000038665.5
|
Ptchd1
|
patched domain containing 1 |
chr17_+_33555719 | 0.75 |
ENSMUST00000087605.5
ENSMUST00000174695.1 |
Myo1f
|
myosin IF |
chr7_+_131032061 | 0.75 |
ENSMUST00000084509.3
|
Dmbt1
|
deleted in malignant brain tumors 1 |
chr3_+_89229046 | 0.75 |
ENSMUST00000041142.3
|
Muc1
|
mucin 1, transmembrane |
chr4_-_130279205 | 0.75 |
ENSMUST00000120126.2
|
Serinc2
|
serine incorporator 2 |
chr11_-_103363431 | 0.75 |
ENSMUST00000092557.5
|
Arhgap27
|
Rho GTPase activating protein 27 |
chr1_+_16688405 | 0.75 |
ENSMUST00000026881.4
|
Ly96
|
lymphocyte antigen 96 |
chr13_-_49309217 | 0.74 |
ENSMUST00000110087.2
|
Fgd3
|
FYVE, RhoGEF and PH domain containing 3 |
chr6_+_125552948 | 0.74 |
ENSMUST00000112254.1
ENSMUST00000112253.1 ENSMUST00000001995.7 |
Vwf
|
Von Willebrand factor homolog |
chr17_-_63499983 | 0.74 |
ENSMUST00000024761.6
|
Fbxl17
|
F-box and leucine-rich repeat protein 17 |
chr6_-_40585783 | 0.74 |
ENSMUST00000177178.1
ENSMUST00000129948.2 ENSMUST00000101491.4 |
Clec5a
|
C-type lectin domain family 5, member a |
chr7_-_127218303 | 0.74 |
ENSMUST00000106313.1
|
Sept1
|
septin 1 |
chr11_+_70647258 | 0.74 |
ENSMUST00000037534.7
|
Rnf167
|
ring finger protein 167 |
chr13_-_110357136 | 0.73 |
ENSMUST00000058806.5
|
Gapt
|
Grb2-binding adaptor, transmembrane |
chr7_+_143473736 | 0.73 |
ENSMUST00000052348.5
|
Slc22a18
|
solute carrier family 22 (organic cation transporter), member 18 |
chr1_+_172555932 | 0.73 |
ENSMUST00000061835.3
|
Vsig8
|
V-set and immunoglobulin domain containing 8 |
chr5_-_123879992 | 0.73 |
ENSMUST00000164267.1
|
Gpr81
|
G protein-coupled receptor 81 |
chr11_-_106973090 | 0.73 |
ENSMUST00000150366.1
|
Gm11707
|
predicted gene 11707 |
chr7_-_100964371 | 0.73 |
ENSMUST00000060174.4
|
P2ry6
|
pyrimidinergic receptor P2Y, G-protein coupled, 6 |
chr16_+_96361654 | 0.73 |
ENSMUST00000113794.1
|
Igsf5
|
immunoglobulin superfamily, member 5 |
chr19_+_32619997 | 0.73 |
ENSMUST00000025833.6
|
Papss2
|
3'-phosphoadenosine 5'-phosphosulfate synthase 2 |
chr11_+_11685909 | 0.72 |
ENSMUST00000065433.5
|
Ikzf1
|
IKAROS family zinc finger 1 |
chr3_-_106167564 | 0.72 |
ENSMUST00000063062.8
|
Chi3l3
|
chitinase 3-like 3 |
chr15_+_100353149 | 0.71 |
ENSMUST00000075675.5
ENSMUST00000088142.5 ENSMUST00000176287.1 |
AB099516
Mettl7a2
|
cDNA sequence AB099516 methyltransferase like 7A2 |
chr3_-_137981523 | 0.71 |
ENSMUST00000136613.1
ENSMUST00000029806.6 |
Dapp1
|
dual adaptor for phosphotyrosine and 3-phosphoinositides 1 |
chr8_-_71723308 | 0.70 |
ENSMUST00000125092.1
|
Fcho1
|
FCH domain only 1 |
chr13_-_37050237 | 0.70 |
ENSMUST00000164727.1
|
F13a1
|
coagulation factor XIII, A1 subunit |
chr4_-_140617062 | 0.70 |
ENSMUST00000154979.1
|
Arhgef10l
|
Rho guanine nucleotide exchange factor (GEF) 10-like |
chr2_+_70563435 | 0.70 |
ENSMUST00000123330.1
|
Gad1
|
glutamate decarboxylase 1 |
chr11_+_58757604 | 0.70 |
ENSMUST00000073005.2
|
Olfr316
|
olfactory receptor 316 |
chr19_+_53460610 | 0.69 |
ENSMUST00000180442.1
|
4833407H14Rik
|
RIKEN cDNA 4833407H14 gene |
chr11_+_4236411 | 0.69 |
ENSMUST00000075221.2
|
Osm
|
oncostatin M |
chr11_-_40755201 | 0.69 |
ENSMUST00000020576.7
|
Ccng1
|
cyclin G1 |
chr4_+_43267165 | 0.68 |
ENSMUST00000107942.2
ENSMUST00000102953.3 |
Atp8b5
|
ATPase, class I, type 8B, member 5 |
chr1_-_120505084 | 0.68 |
ENSMUST00000027639.1
|
Marco
|
macrophage receptor with collagenous structure |
chr7_+_35555367 | 0.68 |
ENSMUST00000181932.1
|
B230322F03Rik
|
RIKEN cDNA B230322F03 gene |
chr16_+_31878810 | 0.68 |
ENSMUST00000023464.5
|
Mfi2
|
antigen p97 (melanoma associated) identified by monoclonal antibodies 133.2 and 96.5 |
chr9_+_56089962 | 0.67 |
ENSMUST00000059206.7
|
Pstpip1
|
proline-serine-threonine phosphatase-interacting protein 1 |
chr15_+_84324716 | 0.67 |
ENSMUST00000023074.2
|
Parvg
|
parvin, gamma |
chr14_+_51129055 | 0.67 |
ENSMUST00000095923.3
|
Rnase6
|
ribonuclease, RNase A family, 6 |
chr16_-_19983005 | 0.67 |
ENSMUST00000058839.8
|
Klhl6
|
kelch-like 6 |
chr2_+_25218741 | 0.67 |
ENSMUST00000028346.3
|
Fam166a
|
family with sequence similarity 166, member A |
chr5_+_30913398 | 0.67 |
ENSMUST00000031055.5
|
Emilin1
|
elastin microfibril interfacer 1 |
chr17_-_46144156 | 0.66 |
ENSMUST00000024762.2
|
Rsph9
|
radial spoke head 9 homolog (Chlamydomonas) |
chr5_-_134229581 | 0.66 |
ENSMUST00000111275.1
ENSMUST00000016094.6 ENSMUST00000144086.1 |
Ncf1
|
neutrophil cytosolic factor 1 |
chr13_-_55021196 | 0.66 |
ENSMUST00000153665.1
|
Hk3
|
hexokinase 3 |
chrX_-_57338598 | 0.66 |
ENSMUST00000033468.4
ENSMUST00000114736.1 |
Arhgef6
|
Rac/Cdc42 guanine nucleotide exchange factor (GEF) 6 |
chr11_+_69965396 | 0.65 |
ENSMUST00000018713.6
|
Cldn7
|
claudin 7 |
chr7_-_121074501 | 0.65 |
ENSMUST00000047194.2
|
Igsf6
|
immunoglobulin superfamily, member 6 |
chr8_+_94923687 | 0.64 |
ENSMUST00000153448.1
ENSMUST00000074570.3 ENSMUST00000166802.1 |
Gpr114
|
G protein-coupled receptor 114 |
chr16_+_44765732 | 0.64 |
ENSMUST00000057488.8
|
Cd200r1
|
CD200 receptor 1 |
chr6_+_48739039 | 0.64 |
ENSMUST00000054368.4
ENSMUST00000140054.1 |
Gimap1
|
GTPase, IMAP family member 1 |
chr9_+_89199209 | 0.64 |
ENSMUST00000068569.4
|
Bcl2a1b
|
B cell leukemia/lymphoma 2 related protein A1b |
chr15_-_66560997 | 0.64 |
ENSMUST00000048372.5
|
Tmem71
|
transmembrane protein 71 |
chr14_-_110755100 | 0.64 |
ENSMUST00000078386.2
|
Slitrk6
|
SLIT and NTRK-like family, member 6 |
chr10_+_34483400 | 0.63 |
ENSMUST00000019913.7
ENSMUST00000170771.1 |
Frk
|
fyn-related kinase |
chr11_-_79523760 | 0.63 |
ENSMUST00000179322.1
|
Evi2b
|
ecotropic viral integration site 2b |
chr10_-_77259223 | 0.63 |
ENSMUST00000105408.3
|
Gm10941
|
predicted gene 10941 |
chr18_+_66458587 | 0.63 |
ENSMUST00000025399.7
|
Pmaip1
|
phorbol-12-myristate-13-acetate-induced protein 1 |
chr2_-_103303179 | 0.62 |
ENSMUST00000090475.3
|
Ehf
|
ets homologous factor |
chr9_-_106476590 | 0.62 |
ENSMUST00000112479.2
|
Parp3
|
poly (ADP-ribose) polymerase family, member 3 |
chr11_-_120727226 | 0.62 |
ENSMUST00000106148.3
ENSMUST00000026144.4 |
Dcxr
|
dicarbonyl L-xylulose reductase |
chr2_-_30903255 | 0.62 |
ENSMUST00000102852.3
|
Ptges
|
prostaglandin E synthase |
chr7_+_12834743 | 0.62 |
ENSMUST00000004614.8
|
Zfp110
|
zinc finger protein 110 |
chr8_+_92827273 | 0.61 |
ENSMUST00000034187.7
|
Mmp2
|
matrix metallopeptidase 2 |
chr9_+_108392820 | 0.61 |
ENSMUST00000035234.4
|
1700102P08Rik
|
RIKEN cDNA 1700102P08 gene |
chr15_-_54278420 | 0.60 |
ENSMUST00000079772.3
|
Tnfrsf11b
|
tumor necrosis factor receptor superfamily, member 11b (osteoprotegerin) |
chr17_-_34862473 | 0.60 |
ENSMUST00000025229.4
ENSMUST00000176203.2 ENSMUST00000128767.1 |
Cfb
|
complement factor B |
chr15_+_102102926 | 0.60 |
ENSMUST00000169627.1
ENSMUST00000046144.9 |
Tenc1
|
tensin like C1 domain-containing phosphatase |
chr9_+_6168601 | 0.60 |
ENSMUST00000168039.1
|
Pdgfd
|
platelet-derived growth factor, D polypeptide |
chr13_-_38036923 | 0.60 |
ENSMUST00000110233.1
ENSMUST00000074969.4 ENSMUST00000131066.1 |
Cage1
|
cancer antigen 1 |
chr11_+_94565039 | 0.60 |
ENSMUST00000040418.8
|
Chad
|
chondroadherin |
chr9_-_21592805 | 0.60 |
ENSMUST00000034700.7
ENSMUST00000180365.1 ENSMUST00000078572.7 |
Yipf2
|
Yip1 domain family, member 2 |
chr16_+_5007306 | 0.59 |
ENSMUST00000178155.2
ENSMUST00000184256.1 ENSMUST00000185147.1 |
Smim22
|
small integral membrane protein 22 |
chr11_-_99986593 | 0.59 |
ENSMUST00000105050.2
|
Krtap16-1
|
keratin associated protein 16-1 |
chr4_+_3678108 | 0.59 |
ENSMUST00000041377.6
ENSMUST00000103010.3 |
Lyn
|
Yamaguchi sarcoma viral (v-yes-1) oncogene homolog |
chr14_-_63417125 | 0.59 |
ENSMUST00000014597.3
|
Blk
|
B lymphoid kinase |
chr7_-_3915501 | 0.59 |
ENSMUST00000038176.8
ENSMUST00000090689.4 |
Lilra6
|
leukocyte immunoglobulin-like receptor, subfamily A (with TM domain), member 6 |
chr19_-_11266122 | 0.59 |
ENSMUST00000169159.1
|
Ms4a1
|
membrane-spanning 4-domains, subfamily A, member 1 |
chr12_-_84698769 | 0.59 |
ENSMUST00000095550.2
|
Syndig1l
|
synapse differentiation inducing 1 like |
chr6_+_86526271 | 0.58 |
ENSMUST00000180896.1
|
1600020E01Rik
|
RIKEN cDNA 1600020E01 gene |
chr13_-_38037069 | 0.58 |
ENSMUST00000089840.4
|
Cage1
|
cancer antigen 1 |
chr5_+_104435112 | 0.58 |
ENSMUST00000031243.8
ENSMUST00000086833.6 ENSMUST00000112748.1 ENSMUST00000112746.1 ENSMUST00000145084.1 ENSMUST00000132457.1 |
Spp1
|
secreted phosphoprotein 1 |
chr3_+_96576984 | 0.58 |
ENSMUST00000148290.1
|
Gm16253
|
predicted gene 16253 |
chr15_-_99705490 | 0.58 |
ENSMUST00000163472.2
|
Gm17349
|
predicted gene, 17349 |
chr11_-_114989854 | 0.58 |
ENSMUST00000045075.2
|
Cd300ld
|
CD300 molecule-like family member d |
chr10_+_95417352 | 0.58 |
ENSMUST00000181781.1
|
5730420D15Rik
|
RIKEN cDNA 5730420D15 gene |
chr8_-_122432924 | 0.58 |
ENSMUST00000017604.8
|
Cyba
|
cytochrome b-245, alpha polypeptide |
chr17_+_69439326 | 0.57 |
ENSMUST00000169935.1
|
A330050F15Rik
|
RIKEN cDNA A330050F15 gene |
chr2_+_165055625 | 0.57 |
ENSMUST00000017799.5
ENSMUST00000073707.2 |
Cd40
|
CD40 antigen |
chr17_-_46890405 | 0.57 |
ENSMUST00000086675.3
|
A330017A19Rik
|
RIKEN cDNA A330017A19 gene |
chr6_-_136941694 | 0.57 |
ENSMUST00000032344.5
|
Arhgdib
|
Rho, GDP dissociation inhibitor (GDI) beta |
chr7_+_44198191 | 0.57 |
ENSMUST00000085450.2
|
Klk1b3
|
kallikrein 1-related peptidase b3 |
chr3_+_90603767 | 0.56 |
ENSMUST00000001046.5
ENSMUST00000107330.1 |
S100a4
|
S100 calcium binding protein A4 |
chr10_-_93310963 | 0.56 |
ENSMUST00000151153.1
|
Elk3
|
ELK3, member of ETS oncogene family |
chr3_+_96670131 | 0.56 |
ENSMUST00000048427.5
|
Ankrd35
|
ankyrin repeat domain 35 |
chr17_-_34031684 | 0.56 |
ENSMUST00000169397.1
|
Slc39a7
|
solute carrier family 39 (zinc transporter), member 7 |
chr14_-_25903100 | 0.56 |
ENSMUST00000052286.8
|
Plac9a
|
placenta specific 9a |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.8 | 5.4 | GO:0070488 | neutrophil aggregation(GO:0070488) |
0.7 | 2.2 | GO:0002884 | negative regulation of hypersensitivity(GO:0002884) |
0.7 | 2.7 | GO:0038094 | Fc-gamma receptor signaling pathway(GO:0038094) |
0.6 | 2.4 | GO:0051311 | spindle assembly involved in female meiosis(GO:0007056) meiotic metaphase plate congression(GO:0051311) |
0.6 | 5.5 | GO:0030886 | negative regulation of myeloid dendritic cell activation(GO:0030886) |
0.6 | 1.1 | GO:0002874 | regulation of chronic inflammatory response to antigenic stimulus(GO:0002874) |
0.5 | 2.3 | GO:0033277 | abortive mitotic cell cycle(GO:0033277) |
0.4 | 2.2 | GO:2000473 | regulation of hematopoietic stem cell migration(GO:2000471) positive regulation of hematopoietic stem cell migration(GO:2000473) |
0.4 | 0.9 | GO:2000439 | positive regulation of monocyte extravasation(GO:2000439) |
0.4 | 1.7 | GO:0035666 | TRIF-dependent toll-like receptor signaling pathway(GO:0035666) |
0.4 | 0.4 | GO:0002434 | immune complex clearance(GO:0002434) immune complex clearance by monocytes and macrophages(GO:0002436) regulation of immune complex clearance by monocytes and macrophages(GO:0090264) positive regulation of immune complex clearance by monocytes and macrophages(GO:0090265) |
0.4 | 1.3 | GO:0006571 | tyrosine biosynthetic process(GO:0006571) aromatic amino acid family biosynthetic process(GO:0009073) aromatic amino acid family biosynthetic process, prephenate pathway(GO:0009095) |
0.4 | 1.3 | GO:2000418 | positive regulation of eosinophil migration(GO:2000418) |
0.4 | 1.2 | GO:0002344 | peripheral B cell selection(GO:0002343) B cell affinity maturation(GO:0002344) |
0.4 | 1.6 | GO:0006742 | NADP catabolic process(GO:0006742) |
0.4 | 1.2 | GO:0045660 | positive regulation of neutrophil differentiation(GO:0045660) |
0.4 | 1.9 | GO:0002003 | angiotensin maturation(GO:0002003) |
0.4 | 1.1 | GO:0071725 | response to triacyl bacterial lipopeptide(GO:0071725) cellular response to triacyl bacterial lipopeptide(GO:0071727) |
0.4 | 0.4 | GO:0015920 | lipopolysaccharide transport(GO:0015920) |
0.3 | 1.0 | GO:2000016 | negative regulation of determination of dorsal identity(GO:2000016) |
0.3 | 1.0 | GO:0002277 | myeloid dendritic cell activation involved in immune response(GO:0002277) |
0.3 | 0.3 | GO:1903237 | negative regulation of leukocyte tethering or rolling(GO:1903237) |
0.3 | 0.3 | GO:2000458 | astrocyte chemotaxis(GO:0035700) regulation of astrocyte chemotaxis(GO:2000458) |
0.3 | 1.2 | GO:0034769 | basement membrane disassembly(GO:0034769) |
0.3 | 0.9 | GO:0046021 | regulation of transcription from RNA polymerase II promoter, mitotic(GO:0046021) positive regulation of transcription from RNA polymerase II promoter during mitosis(GO:0046022) |
0.3 | 0.9 | GO:0043311 | regulation of eosinophil degranulation(GO:0043309) positive regulation of eosinophil degranulation(GO:0043311) positive regulation of eosinophil activation(GO:1902568) |
0.3 | 0.6 | GO:0002678 | positive regulation of chronic inflammatory response(GO:0002678) |
0.3 | 0.6 | GO:2000410 | regulation of thymocyte migration(GO:2000410) positive regulation of thymocyte migration(GO:2000412) |
0.3 | 0.3 | GO:0033634 | positive regulation of cell-cell adhesion mediated by integrin(GO:0033634) |
0.3 | 1.1 | GO:0006069 | ethanol oxidation(GO:0006069) |
0.3 | 0.5 | GO:1902022 | L-lysine transport(GO:1902022) |
0.3 | 0.8 | GO:0030200 | heparan sulfate proteoglycan catabolic process(GO:0030200) |
0.2 | 0.7 | GO:0032497 | detection of lipopolysaccharide(GO:0032497) |
0.2 | 1.6 | GO:0009449 | gamma-aminobutyric acid biosynthetic process(GO:0009449) |
0.2 | 1.2 | GO:0045347 | negative regulation of MHC class II biosynthetic process(GO:0045347) |
0.2 | 0.7 | GO:2000670 | positive regulation of dendritic cell apoptotic process(GO:2000670) |
0.2 | 0.7 | GO:1903903 | regulation of establishment of T cell polarity(GO:1903903) |
0.2 | 0.9 | GO:0014722 | regulation of skeletal muscle contraction by calcium ion signaling(GO:0014722) |
0.2 | 1.1 | GO:0001692 | histamine metabolic process(GO:0001692) |
0.2 | 0.6 | GO:0060005 | vestibular reflex(GO:0060005) |
0.2 | 0.6 | GO:1990166 | protein localization to site of double-strand break(GO:1990166) |
0.2 | 0.6 | GO:0042732 | D-xylose metabolic process(GO:0042732) |
0.2 | 1.2 | GO:0002291 | T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell(GO:0002291) |
0.2 | 1.4 | GO:0061074 | regulation of neural retina development(GO:0061074) |
0.2 | 0.2 | GO:0060842 | arterial endothelial cell differentiation(GO:0060842) |
0.2 | 10.0 | GO:0070098 | chemokine-mediated signaling pathway(GO:0070098) |
0.2 | 0.6 | GO:0002305 | gamma-delta intraepithelial T cell differentiation(GO:0002304) CD8-positive, gamma-delta intraepithelial T cell differentiation(GO:0002305) |
0.2 | 1.6 | GO:0016584 | nucleosome positioning(GO:0016584) |
0.2 | 0.6 | GO:0006710 | androgen catabolic process(GO:0006710) estradiol secretion(GO:0035938) regulation of estradiol secretion(GO:2000864) |
0.2 | 0.6 | GO:0002019 | regulation of renal output by angiotensin(GO:0002019) |
0.2 | 0.8 | GO:0044849 | estrous cycle(GO:0044849) |
0.2 | 0.6 | GO:0006601 | creatine biosynthetic process(GO:0006601) |
0.2 | 0.6 | GO:0032960 | regulation of inositol trisphosphate biosynthetic process(GO:0032960) positive regulation of inositol trisphosphate biosynthetic process(GO:0032962) |
0.2 | 0.6 | GO:0032241 | positive regulation of nucleobase-containing compound transport(GO:0032241) |
0.2 | 1.1 | GO:0036258 | multivesicular body assembly(GO:0036258) |
0.2 | 0.6 | GO:0006011 | UDP-glucose metabolic process(GO:0006011) |
0.2 | 0.4 | GO:0009804 | coumarin metabolic process(GO:0009804) phenylpropanoid catabolic process(GO:0046271) |
0.2 | 1.5 | GO:1901164 | negative regulation of trophoblast cell migration(GO:1901164) |
0.2 | 0.7 | GO:1904139 | microglial cell migration(GO:1904124) regulation of microglial cell migration(GO:1904139) |
0.2 | 4.4 | GO:0045730 | respiratory burst(GO:0045730) |
0.2 | 0.4 | GO:2000449 | regulation of CD8-positive, alpha-beta T cell extravasation(GO:2000449) |
0.2 | 0.7 | GO:0043376 | regulation of CD8-positive, alpha-beta T cell differentiation(GO:0043376) |
0.2 | 1.0 | GO:0002248 | connective tissue replacement involved in inflammatory response wound healing(GO:0002248) |
0.2 | 0.9 | GO:0007403 | glial cell fate determination(GO:0007403) |
0.2 | 0.2 | GO:0042494 | detection of bacterial lipoprotein(GO:0042494) |
0.2 | 0.5 | GO:0072301 | negative regulation of metanephric glomerulus development(GO:0072299) regulation of metanephric glomerular mesangial cell proliferation(GO:0072301) negative regulation of metanephric glomerular mesangial cell proliferation(GO:0072302) regulation of metanephric ureteric bud development(GO:2001074) positive regulation of metanephric ureteric bud development(GO:2001076) |
0.2 | 0.2 | GO:0042322 | negative regulation of circadian sleep/wake cycle, REM sleep(GO:0042322) |
0.2 | 1.8 | GO:0072378 | blood coagulation, fibrin clot formation(GO:0072378) |
0.2 | 0.5 | GO:0090004 | positive regulation of Golgi to plasma membrane protein transport(GO:0042998) positive regulation of establishment of protein localization to plasma membrane(GO:0090004) |
0.2 | 0.8 | GO:1903232 | melanosome assembly(GO:1903232) |
0.2 | 0.2 | GO:0032690 | negative regulation of interleukin-1 alpha production(GO:0032690) negative regulation of interleukin-1 alpha secretion(GO:0050712) |
0.2 | 1.1 | GO:0016198 | axon choice point recognition(GO:0016198) |
0.2 | 1.0 | GO:0032929 | negative regulation of superoxide anion generation(GO:0032929) |
0.2 | 0.2 | GO:0045608 | inhibition of neuroepithelial cell differentiation(GO:0002085) negative regulation of auditory receptor cell differentiation(GO:0045608) |
0.2 | 0.5 | GO:0002322 | B cell proliferation involved in immune response(GO:0002322) |
0.2 | 0.6 | GO:1900740 | regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:1900739) positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:1900740) |
0.2 | 0.3 | GO:0001999 | renal response to blood flow involved in circulatory renin-angiotensin regulation of systemic arterial blood pressure(GO:0001999) renin secretion into blood stream(GO:0002001) regulation of renin secretion into blood stream(GO:1900133) |
0.2 | 0.2 | GO:0002865 | negative regulation of acute inflammatory response to antigenic stimulus(GO:0002865) |
0.2 | 0.6 | GO:0014012 | peripheral nervous system axon regeneration(GO:0014012) |
0.2 | 0.9 | GO:0016081 | synaptic vesicle docking(GO:0016081) |
0.1 | 0.7 | GO:0000103 | sulfate assimilation(GO:0000103) |
0.1 | 0.4 | GO:0019046 | release from viral latency(GO:0019046) |
0.1 | 0.9 | GO:0045743 | positive regulation of fibroblast growth factor receptor signaling pathway(GO:0045743) |
0.1 | 1.1 | GO:0002349 | histamine production involved in inflammatory response(GO:0002349) histamine secretion involved in inflammatory response(GO:0002441) histamine secretion by mast cell(GO:0002553) |
0.1 | 0.7 | GO:0035752 | lysosomal lumen pH elevation(GO:0035752) |
0.1 | 0.7 | GO:0060478 | acrosomal vesicle exocytosis(GO:0060478) |
0.1 | 0.7 | GO:0019086 | late viral transcription(GO:0019086) |
0.1 | 0.8 | GO:0071787 | endoplasmic reticulum tubular network assembly(GO:0071787) |
0.1 | 0.6 | GO:1903225 | negative regulation of endodermal cell differentiation(GO:1903225) |
0.1 | 0.4 | GO:0034443 | regulation of lipoprotein oxidation(GO:0034442) negative regulation of lipoprotein oxidation(GO:0034443) |
0.1 | 0.4 | GO:0048209 | regulation of vesicle targeting, to, from or within Golgi(GO:0048209) |
0.1 | 0.5 | GO:2001287 | negative regulation of caveolin-mediated endocytosis(GO:2001287) |
0.1 | 0.4 | GO:0035574 | histone H4-K20 demethylation(GO:0035574) |
0.1 | 0.3 | GO:0003331 | regulation of extracellular matrix constituent secretion(GO:0003330) positive regulation of extracellular matrix constituent secretion(GO:0003331) |
0.1 | 1.7 | GO:0010455 | positive regulation of cell fate commitment(GO:0010455) |
0.1 | 0.1 | GO:0002924 | negative regulation of humoral immune response mediated by circulating immunoglobulin(GO:0002924) |
0.1 | 1.1 | GO:0009181 | purine nucleoside diphosphate catabolic process(GO:0009137) purine ribonucleoside diphosphate catabolic process(GO:0009181) |
0.1 | 0.8 | GO:0061303 | cornea development in camera-type eye(GO:0061303) |
0.1 | 0.4 | GO:0051464 | cortisol secretion(GO:0043400) regulation of cortisol secretion(GO:0051462) positive regulation of cortisol secretion(GO:0051464) |
0.1 | 1.2 | GO:0070474 | positive regulation of uterine smooth muscle contraction(GO:0070474) |
0.1 | 1.9 | GO:1901299 | negative regulation of hydrogen peroxide-mediated programmed cell death(GO:1901299) |
0.1 | 0.8 | GO:1990592 | protein polyufmylation(GO:1990564) protein K69-linked ufmylation(GO:1990592) |
0.1 | 0.3 | GO:0002725 | negative regulation of T cell cytokine production(GO:0002725) |
0.1 | 0.6 | GO:0038165 | oncostatin-M-mediated signaling pathway(GO:0038165) |
0.1 | 0.4 | GO:0045715 | negative regulation of low-density lipoprotein particle receptor biosynthetic process(GO:0045715) |
0.1 | 0.5 | GO:1903896 | positive regulation of IRE1-mediated unfolded protein response(GO:1903896) |
0.1 | 0.5 | GO:0045658 | regulation of neutrophil differentiation(GO:0045658) negative regulation of neutrophil differentiation(GO:0045659) |
0.1 | 0.5 | GO:0071608 | macrophage inflammatory protein-1 alpha production(GO:0071608) |
0.1 | 0.8 | GO:0032439 | endosome localization(GO:0032439) |
0.1 | 0.5 | GO:0090383 | phagosome acidification(GO:0090383) |
0.1 | 2.7 | GO:0071577 | zinc II ion transmembrane transport(GO:0071577) |
0.1 | 0.2 | GO:0061357 | positive regulation of Wnt protein secretion(GO:0061357) |
0.1 | 0.2 | GO:0002426 | immunoglobulin production in mucosal tissue(GO:0002426) |
0.1 | 2.8 | GO:0071501 | response to sterol depletion(GO:0006991) SREBP signaling pathway(GO:0032933) cellular response to sterol depletion(GO:0071501) |
0.1 | 0.2 | GO:0002408 | myeloid dendritic cell chemotaxis(GO:0002408) |
0.1 | 0.4 | GO:0070315 | G1 to G0 transition involved in cell differentiation(GO:0070315) |
0.1 | 0.2 | GO:0046104 | thymidine metabolic process(GO:0046104) |
0.1 | 0.2 | GO:1901662 | phylloquinone metabolic process(GO:0042374) phylloquinone catabolic process(GO:0042376) quinone catabolic process(GO:1901662) |
0.1 | 0.1 | GO:1903406 | regulation of sodium:potassium-exchanging ATPase activity(GO:1903406) |
0.1 | 0.1 | GO:0042119 | neutrophil activation(GO:0042119) |
0.1 | 0.2 | GO:0046013 | regulation of T cell homeostatic proliferation(GO:0046013) |
0.1 | 0.8 | GO:2000427 | positive regulation of apoptotic cell clearance(GO:2000427) |
0.1 | 0.1 | GO:0042231 | interleukin-13 biosynthetic process(GO:0042231) |
0.1 | 0.6 | GO:0007386 | compartment pattern specification(GO:0007386) |
0.1 | 0.3 | GO:0045136 | development of secondary sexual characteristics(GO:0045136) development of secondary female sexual characteristics(GO:0046543) |
0.1 | 0.2 | GO:0006680 | glucosylceramide catabolic process(GO:0006680) |
0.1 | 0.2 | GO:0032100 | positive regulation of response to food(GO:0032097) positive regulation of appetite(GO:0032100) |
0.1 | 0.4 | GO:0071449 | response to lipid hydroperoxide(GO:0006982) cellular response to lipid hydroperoxide(GO:0071449) |
0.1 | 0.9 | GO:1902730 | positive regulation of proteoglycan biosynthetic process(GO:1902730) |
0.1 | 0.5 | GO:0050651 | dermatan sulfate proteoglycan biosynthetic process(GO:0050651) |
0.1 | 0.9 | GO:0045073 | chemokine biosynthetic process(GO:0042033) regulation of chemokine biosynthetic process(GO:0045073) |
0.1 | 0.4 | GO:0090126 | protein complex assembly involved in synapse maturation(GO:0090126) |
0.1 | 1.1 | GO:0032494 | response to peptidoglycan(GO:0032494) |
0.1 | 0.3 | GO:1900106 | hyaluranon cable assembly(GO:0036118) regulation of hyaluranon cable assembly(GO:1900104) positive regulation of hyaluranon cable assembly(GO:1900106) |
0.1 | 0.9 | GO:0007406 | negative regulation of neuroblast proliferation(GO:0007406) |
0.1 | 0.7 | GO:0045084 | positive regulation of interleukin-12 biosynthetic process(GO:0045084) |
0.1 | 0.7 | GO:1904222 | regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904217) positive regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904219) positive regulation of serine C-palmitoyltransferase activity(GO:1904222) |
0.1 | 0.3 | GO:0003099 | positive regulation of the force of heart contraction by epinephrine-norepinephrine(GO:0001997) positive regulation of the force of heart contraction by chemical signal(GO:0003099) |
0.1 | 0.3 | GO:1904154 | positive regulation of retrograde protein transport, ER to cytosol(GO:1904154) |
0.1 | 0.6 | GO:0006663 | platelet activating factor biosynthetic process(GO:0006663) |
0.1 | 0.3 | GO:0006713 | glucocorticoid catabolic process(GO:0006713) |
0.1 | 0.3 | GO:2000642 | negative regulation of early endosome to late endosome transport(GO:2000642) |
0.1 | 0.7 | GO:2000980 | regulation of auditory receptor cell differentiation(GO:0045607) regulation of mechanoreceptor differentiation(GO:0045631) regulation of inner ear receptor cell differentiation(GO:2000980) |
0.1 | 0.5 | GO:0097118 | neuroligin clustering involved in postsynaptic membrane assembly(GO:0097118) |
0.1 | 1.1 | GO:0006957 | complement activation, alternative pathway(GO:0006957) |
0.1 | 0.2 | GO:0071873 | response to norepinephrine(GO:0071873) |
0.1 | 0.7 | GO:0048102 | autophagic cell death(GO:0048102) |
0.1 | 0.6 | GO:0006685 | sphingomyelin catabolic process(GO:0006685) |
0.1 | 0.3 | GO:0006532 | aspartate biosynthetic process(GO:0006532) |
0.1 | 0.3 | GO:0009436 | glyoxylate catabolic process(GO:0009436) |
0.1 | 1.1 | GO:0034498 | early endosome to Golgi transport(GO:0034498) |
0.1 | 0.1 | GO:0001928 | regulation of exocyst assembly(GO:0001928) |
0.1 | 0.3 | GO:0045590 | negative regulation of regulatory T cell differentiation(GO:0045590) |
0.1 | 0.5 | GO:0045163 | clustering of voltage-gated potassium channels(GO:0045163) |
0.1 | 2.1 | GO:0007095 | mitotic G2 DNA damage checkpoint(GO:0007095) |
0.1 | 0.6 | GO:0030321 | transepithelial chloride transport(GO:0030321) |
0.1 | 0.2 | GO:1904305 | negative regulation of gastro-intestinal system smooth muscle contraction(GO:1904305) regulation of small intestine smooth muscle contraction(GO:1904347) negative regulation of small intestine smooth muscle contraction(GO:1904348) small intestine smooth muscle contraction(GO:1990770) |
0.1 | 0.2 | GO:0048550 | negative regulation of pinocytosis(GO:0048550) |
0.1 | 0.4 | GO:0042985 | negative regulation of amyloid precursor protein biosynthetic process(GO:0042985) |
0.1 | 0.1 | GO:1905063 | regulation of vascular smooth muscle cell differentiation(GO:1905063) |
0.1 | 0.3 | GO:0032713 | negative regulation of interleukin-4 production(GO:0032713) |
0.1 | 0.1 | GO:0014054 | positive regulation of gamma-aminobutyric acid secretion(GO:0014054) |
0.1 | 4.9 | GO:0006911 | phagocytosis, engulfment(GO:0006911) |
0.1 | 0.4 | GO:0008594 | photoreceptor cell morphogenesis(GO:0008594) |
0.1 | 0.1 | GO:0021622 | oculomotor nerve morphogenesis(GO:0021622) oculomotor nerve formation(GO:0021623) |
0.1 | 0.3 | GO:1904579 | response to thapsigargin(GO:1904578) cellular response to thapsigargin(GO:1904579) |
0.1 | 0.3 | GO:0035694 | mitochondrial protein catabolic process(GO:0035694) |
0.1 | 0.4 | GO:0051122 | hepoxilin metabolic process(GO:0051121) hepoxilin biosynthetic process(GO:0051122) |
0.1 | 0.2 | GO:0061030 | epithelial cell differentiation involved in mammary gland alveolus development(GO:0061030) |
0.1 | 0.2 | GO:0035483 | gastric emptying(GO:0035483) |
0.1 | 0.4 | GO:0015860 | purine nucleoside transmembrane transport(GO:0015860) nucleoside transmembrane transport(GO:1901642) |
0.1 | 1.7 | GO:0032463 | negative regulation of protein homooligomerization(GO:0032463) |
0.1 | 0.7 | GO:0035021 | negative regulation of Rac protein signal transduction(GO:0035021) |
0.1 | 0.9 | GO:0030836 | positive regulation of actin filament depolymerization(GO:0030836) |
0.1 | 0.4 | GO:0006559 | L-phenylalanine catabolic process(GO:0006559) erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process(GO:1902222) |
0.1 | 1.1 | GO:0043249 | erythrocyte maturation(GO:0043249) |
0.1 | 0.8 | GO:0071763 | nuclear membrane organization(GO:0071763) |
0.1 | 0.3 | GO:0019859 | pyrimidine nucleobase catabolic process(GO:0006208) thymine catabolic process(GO:0006210) thymine metabolic process(GO:0019859) |
0.1 | 1.0 | GO:0032740 | positive regulation of interleukin-17 production(GO:0032740) |
0.1 | 0.3 | GO:0046351 | disaccharide biosynthetic process(GO:0046351) |
0.1 | 0.3 | GO:0002457 | T cell antigen processing and presentation(GO:0002457) |
0.1 | 1.1 | GO:0002283 | neutrophil activation involved in immune response(GO:0002283) |
0.1 | 0.4 | GO:0010626 | negative regulation of Schwann cell proliferation(GO:0010626) |
0.1 | 0.8 | GO:0060974 | neural crest cell migration involved in heart formation(GO:0003147) cell migration involved in heart formation(GO:0060974) anterior neural tube closure(GO:0061713) cellular response to folic acid(GO:0071231) |
0.1 | 0.2 | GO:0036092 | phosphatidylinositol-3-phosphate biosynthetic process(GO:0036092) |
0.1 | 0.3 | GO:1903898 | negative regulation of PERK-mediated unfolded protein response(GO:1903898) |
0.1 | 0.2 | GO:0030908 | intein-mediated protein splicing(GO:0016539) protein splicing(GO:0030908) |
0.1 | 0.3 | GO:0032701 | negative regulation of granulocyte macrophage colony-stimulating factor production(GO:0032685) negative regulation of interleukin-18 production(GO:0032701) |
0.1 | 0.3 | GO:0061343 | cell adhesion involved in heart morphogenesis(GO:0061343) |
0.1 | 0.3 | GO:0018199 | peptidyl-glutamine modification(GO:0018199) |
0.1 | 0.1 | GO:1902202 | regulation of hepatocyte growth factor receptor signaling pathway(GO:1902202) |
0.1 | 0.8 | GO:2001214 | positive regulation of vasculogenesis(GO:2001214) |
0.1 | 0.3 | GO:0006049 | UDP-N-acetylglucosamine catabolic process(GO:0006049) |
0.1 | 0.2 | GO:0032696 | negative regulation of interleukin-13 production(GO:0032696) |
0.1 | 0.4 | GO:0007258 | JUN phosphorylation(GO:0007258) |
0.1 | 0.3 | GO:1901421 | positive regulation of response to alcohol(GO:1901421) |
0.1 | 0.4 | GO:0042360 | vitamin E metabolic process(GO:0042360) |
0.1 | 0.4 | GO:0072386 | stress granule disassembly(GO:0035617) plus-end-directed vesicle transport along microtubule(GO:0072383) plus-end-directed organelle transport along microtubule(GO:0072386) |
0.1 | 1.1 | GO:0034505 | tooth mineralization(GO:0034505) |
0.1 | 0.7 | GO:0071493 | cellular response to UV-B(GO:0071493) |
0.1 | 0.2 | GO:0032829 | regulation of CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation(GO:0032829) positive regulation of CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation(GO:0032831) |
0.1 | 1.2 | GO:0033005 | positive regulation of mast cell activation(GO:0033005) |
0.1 | 0.8 | GO:0042483 | negative regulation of odontogenesis(GO:0042483) |
0.1 | 0.2 | GO:0000414 | regulation of histone H3-K36 methylation(GO:0000414) |
0.1 | 0.7 | GO:0003096 | renal sodium ion transport(GO:0003096) |
0.1 | 0.4 | GO:2000255 | negative regulation of male germ cell proliferation(GO:2000255) |
0.1 | 0.2 | GO:0090526 | regulation of gluconeogenesis involved in cellular glucose homeostasis(GO:0090526) |
0.1 | 0.8 | GO:1990440 | positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress(GO:1990440) |
0.1 | 1.4 | GO:0002495 | antigen processing and presentation of peptide antigen via MHC class II(GO:0002495) antigen processing and presentation of peptide or polysaccharide antigen via MHC class II(GO:0002504) |
0.1 | 0.3 | GO:1903288 | positive regulation of potassium ion import(GO:1903288) |
0.1 | 2.0 | GO:0042832 | defense response to protozoan(GO:0042832) |
0.1 | 0.2 | GO:0048743 | positive regulation of skeletal muscle fiber development(GO:0048743) |
0.1 | 1.5 | GO:0007175 | negative regulation of epidermal growth factor-activated receptor activity(GO:0007175) |
0.1 | 0.7 | GO:0070269 | pyroptosis(GO:0070269) |
0.1 | 0.2 | GO:2000349 | regulation of granuloma formation(GO:0002631) negative regulation of granuloma formation(GO:0002632) regulation of toll-like receptor 5 signaling pathway(GO:0034147) negative regulation of toll-like receptor 5 signaling pathway(GO:0034148) negative regulation of nucleotide-binding oligomerization domain containing 1 signaling pathway(GO:0070429) tolerance induction to lipopolysaccharide(GO:0072573) negative regulation of CD40 signaling pathway(GO:2000349) |
0.1 | 0.2 | GO:0009726 | detection of nodal flow(GO:0003127) detection of endogenous stimulus(GO:0009726) |
0.1 | 0.5 | GO:2001280 | positive regulation of prostaglandin biosynthetic process(GO:0031394) positive regulation of unsaturated fatty acid biosynthetic process(GO:2001280) |
0.1 | 0.2 | GO:1904719 | excitatory chemical synaptic transmission(GO:0098976) positive regulation of AMPA glutamate receptor clustering(GO:1904719) |
0.1 | 0.5 | GO:0019087 | transformation of host cell by virus(GO:0019087) |
0.1 | 0.3 | GO:0032468 | cellular manganese ion homeostasis(GO:0030026) Golgi calcium ion homeostasis(GO:0032468) manganese ion homeostasis(GO:0055071) |
0.1 | 0.2 | GO:0061314 | Notch signaling involved in heart development(GO:0061314) |
0.1 | 0.2 | GO:0050859 | negative regulation of B cell receptor signaling pathway(GO:0050859) |
0.1 | 0.3 | GO:1903575 | cornified envelope assembly(GO:1903575) |
0.1 | 0.2 | GO:1901857 | positive regulation of cellular respiration(GO:1901857) |
0.1 | 1.0 | GO:0035845 | photoreceptor cell outer segment organization(GO:0035845) |
0.1 | 0.2 | GO:0061152 | trachea submucosa development(GO:0061152) trachea gland development(GO:0061153) |
0.1 | 0.2 | GO:1902498 | regulation of protein autoubiquitination(GO:1902498) |
0.1 | 1.3 | GO:1990001 | inhibition of cysteine-type endopeptidase activity involved in apoptotic process(GO:1990001) |
0.1 | 0.1 | GO:0046122 | purine deoxyribonucleoside metabolic process(GO:0046122) |
0.1 | 0.9 | GO:0097067 | cellular response to thyroid hormone stimulus(GO:0097067) |
0.1 | 0.4 | GO:0003406 | retinal pigment epithelium development(GO:0003406) |
0.1 | 0.4 | GO:0070447 | positive regulation of oligodendrocyte progenitor proliferation(GO:0070447) |
0.1 | 0.1 | GO:0042222 | interleukin-1 biosynthetic process(GO:0042222) |
0.1 | 0.4 | GO:0023041 | neuronal signal transduction(GO:0023041) |
0.1 | 0.2 | GO:0021603 | cranial nerve formation(GO:0021603) |
0.1 | 0.4 | GO:0034058 | endosomal vesicle fusion(GO:0034058) |
0.1 | 0.1 | GO:0048852 | diencephalon morphogenesis(GO:0048852) |
0.1 | 0.2 | GO:2000729 | positive regulation of mesenchymal cell proliferation involved in ureter development(GO:2000729) |
0.1 | 0.4 | GO:0035864 | response to potassium ion(GO:0035864) cellular response to potassium ion(GO:0035865) |
0.1 | 0.3 | GO:0045054 | constitutive secretory pathway(GO:0045054) |
0.1 | 0.4 | GO:0002159 | desmosome assembly(GO:0002159) |
0.1 | 0.4 | GO:0061588 | calcium activated phospholipid scrambling(GO:0061588) calcium activated phosphatidylcholine scrambling(GO:0061590) calcium activated galactosylceramide scrambling(GO:0061591) |
0.1 | 0.4 | GO:0038161 | prolactin signaling pathway(GO:0038161) |
0.1 | 0.2 | GO:0061763 | multivesicular body-lysosome fusion(GO:0061763) |
0.1 | 0.2 | GO:0032510 | endosome to lysosome transport via multivesicular body sorting pathway(GO:0032510) |
0.1 | 0.5 | GO:0061469 | regulation of type B pancreatic cell proliferation(GO:0061469) |
0.1 | 0.2 | GO:0015910 | peroxisomal long-chain fatty acid import(GO:0015910) |
0.1 | 0.3 | GO:0001923 | B-1 B cell differentiation(GO:0001923) |
0.1 | 0.1 | GO:2001245 | regulation of phosphatidylcholine biosynthetic process(GO:2001245) |
0.1 | 0.2 | GO:0070358 | actin polymerization-dependent cell motility(GO:0070358) |
0.1 | 0.3 | GO:2000705 | regulation of dense core granule biogenesis(GO:2000705) |
0.1 | 1.3 | GO:0045671 | negative regulation of osteoclast differentiation(GO:0045671) |
0.1 | 0.6 | GO:0030889 | negative regulation of B cell proliferation(GO:0030889) |
0.1 | 0.5 | GO:0090385 | phagosome-lysosome fusion(GO:0090385) |
0.1 | 0.3 | GO:0015691 | vanadium ion transport(GO:0015676) cadmium ion transport(GO:0015691) lead ion transport(GO:0015692) cadmium ion transmembrane transport(GO:0070574) |
0.1 | 1.0 | GO:0043517 | positive regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043517) |
0.1 | 0.1 | GO:1902774 | late endosome to lysosome transport(GO:1902774) |
0.1 | 0.4 | GO:0006621 | protein retention in ER lumen(GO:0006621) |
0.1 | 0.1 | GO:0044240 | multicellular organism lipid catabolic process(GO:0044240) |
0.1 | 0.5 | GO:0031274 | positive regulation of pseudopodium assembly(GO:0031274) |
0.1 | 0.5 | GO:0033631 | cell-cell adhesion mediated by integrin(GO:0033631) |
0.1 | 0.2 | GO:0002355 | detection of tumor cell(GO:0002355) |
0.1 | 0.2 | GO:0035726 | common myeloid progenitor cell proliferation(GO:0035726) |
0.1 | 0.2 | GO:2000872 | positive regulation of progesterone secretion(GO:2000872) |
0.1 | 0.1 | GO:0001992 | regulation of systemic arterial blood pressure by vasopressin(GO:0001992) |
0.1 | 0.1 | GO:0032472 | Golgi calcium ion transport(GO:0032472) |
0.1 | 0.1 | GO:2000774 | positive regulation of cell aging(GO:0090343) positive regulation of cellular senescence(GO:2000774) |
0.1 | 0.1 | GO:0006701 | progesterone biosynthetic process(GO:0006701) |
0.1 | 0.2 | GO:0018008 | N-terminal peptidyl-glycine N-myristoylation(GO:0018008) |
0.1 | 0.3 | GO:0035590 | purinergic nucleotide receptor signaling pathway(GO:0035590) |
0.1 | 0.1 | GO:0043974 | histone H3-K27 acetylation(GO:0043974) regulation of histone H3-K27 acetylation(GO:1901674) |
0.1 | 0.2 | GO:0042482 | positive regulation of odontogenesis(GO:0042482) |
0.1 | 0.4 | GO:0045200 | establishment or maintenance of neuroblast polarity(GO:0045196) establishment of neuroblast polarity(GO:0045200) |
0.1 | 0.1 | GO:0045348 | positive regulation of MHC class II biosynthetic process(GO:0045348) |
0.1 | 0.3 | GO:0001920 | negative regulation of receptor recycling(GO:0001920) |
0.1 | 0.3 | GO:0051012 | microtubule sliding(GO:0051012) |
0.1 | 0.5 | GO:0010572 | positive regulation of platelet activation(GO:0010572) |
0.1 | 1.8 | GO:0050853 | B cell receptor signaling pathway(GO:0050853) |
0.1 | 0.6 | GO:0019511 | peptidyl-proline hydroxylation(GO:0019511) |
0.1 | 0.8 | GO:0043568 | positive regulation of insulin-like growth factor receptor signaling pathway(GO:0043568) |
0.1 | 1.0 | GO:0035634 | response to stilbenoid(GO:0035634) |
0.1 | 0.6 | GO:0070257 | positive regulation of mucus secretion(GO:0070257) |
0.1 | 0.2 | GO:0002030 | inhibitory G-protein coupled receptor phosphorylation(GO:0002030) |
0.1 | 0.2 | GO:0043988 | histone H3-S28 phosphorylation(GO:0043988) |
0.1 | 0.1 | GO:0097029 | mature conventional dendritic cell differentiation(GO:0097029) |
0.1 | 0.2 | GO:0002414 | immunoglobulin transcytosis in epithelial cells(GO:0002414) |
0.1 | 0.3 | GO:0021886 | hypothalamus gonadotrophin-releasing hormone neuron differentiation(GO:0021886) hypothalamus gonadotrophin-releasing hormone neuron development(GO:0021888) |
0.1 | 0.2 | GO:0042758 | long-chain fatty acid catabolic process(GO:0042758) |
0.1 | 0.3 | GO:0060923 | cardiac muscle cell fate commitment(GO:0060923) |
0.1 | 0.2 | GO:1900477 | negative regulation of G1/S transition of mitotic cell cycle by negative regulation of transcription from RNA polymerase II promoter(GO:1900477) |
0.1 | 0.7 | GO:0060294 | cilium movement involved in cell motility(GO:0060294) |
0.1 | 0.4 | GO:0003376 | sphingosine-1-phosphate signaling pathway(GO:0003376) |
0.1 | 0.3 | GO:0043589 | skin morphogenesis(GO:0043589) |
0.1 | 0.1 | GO:0006154 | adenosine catabolic process(GO:0006154) |
0.1 | 0.3 | GO:0032796 | uropod organization(GO:0032796) |
0.1 | 0.2 | GO:1900620 | acetylcholine biosynthetic process(GO:0008292) acetate ester biosynthetic process(GO:1900620) |
0.1 | 0.2 | GO:2000562 | regulation of CD4-positive, alpha-beta T cell proliferation(GO:2000561) negative regulation of CD4-positive, alpha-beta T cell proliferation(GO:2000562) |
0.1 | 0.3 | GO:0032224 | positive regulation of synaptic transmission, cholinergic(GO:0032224) |
0.1 | 0.4 | GO:0032096 | negative regulation of response to food(GO:0032096) |
0.1 | 0.2 | GO:0072737 | response to diamide(GO:0072737) cellular response to diamide(GO:0072738) |
0.1 | 0.5 | GO:0045835 | negative regulation of meiotic nuclear division(GO:0045835) |
0.1 | 0.2 | GO:0048007 | antigen processing and presentation of lipid antigen via MHC class Ib(GO:0048003) antigen processing and presentation, exogenous lipid antigen via MHC class Ib(GO:0048007) |
0.1 | 0.2 | GO:0002756 | MyD88-independent toll-like receptor signaling pathway(GO:0002756) |
0.1 | 0.1 | GO:1903279 | regulation of calcium:sodium antiporter activity(GO:1903279) |
0.1 | 0.5 | GO:0000188 | inactivation of MAPK activity(GO:0000188) |
0.1 | 0.7 | GO:0060352 | cell adhesion molecule production(GO:0060352) |
0.1 | 0.4 | GO:0030644 | cellular chloride ion homeostasis(GO:0030644) |
0.1 | 0.2 | GO:0035526 | retrograde transport, plasma membrane to Golgi(GO:0035526) |
0.1 | 0.3 | GO:0031282 | regulation of guanylate cyclase activity(GO:0031282) |
0.1 | 0.2 | GO:0046947 | hydroxylysine metabolic process(GO:0046946) hydroxylysine biosynthetic process(GO:0046947) |
0.1 | 0.4 | GO:0010727 | negative regulation of hydrogen peroxide metabolic process(GO:0010727) |
0.1 | 0.2 | GO:1904431 | positive regulation of t-circle formation(GO:1904431) |
0.1 | 0.4 | GO:0000098 | sulfur amino acid catabolic process(GO:0000098) |
0.0 | 0.7 | GO:0036158 | outer dynein arm assembly(GO:0036158) |
0.0 | 0.3 | GO:0044375 | regulation of peroxisome size(GO:0044375) |
0.0 | 0.5 | GO:0002446 | neutrophil mediated immunity(GO:0002446) |
0.0 | 0.3 | GO:0007221 | positive regulation of transcription of Notch receptor target(GO:0007221) |
0.0 | 0.1 | GO:0034116 | positive regulation of heterotypic cell-cell adhesion(GO:0034116) |
0.0 | 0.7 | GO:0001516 | prostaglandin biosynthetic process(GO:0001516) prostanoid biosynthetic process(GO:0046457) |
0.0 | 0.2 | GO:0098886 | modification of dendritic spine(GO:0098886) |
0.0 | 0.1 | GO:0035106 | operant conditioning(GO:0035106) |
0.0 | 0.3 | GO:0048853 | forebrain morphogenesis(GO:0048853) |
0.0 | 0.3 | GO:0051775 | response to redox state(GO:0051775) |
0.0 | 0.2 | GO:0018406 | protein C-linked glycosylation(GO:0018103) peptidyl-tryptophan modification(GO:0018211) protein C-linked glycosylation via tryptophan(GO:0018317) protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan(GO:0018406) |
0.0 | 0.2 | GO:0010700 | negative regulation of norepinephrine secretion(GO:0010700) |
0.0 | 0.3 | GO:1990009 | retinal cell apoptotic process(GO:1990009) |
0.0 | 0.2 | GO:0044351 | macropinocytosis(GO:0044351) |
0.0 | 0.4 | GO:0015868 | purine ribonucleotide transport(GO:0015868) |
0.0 | 0.2 | GO:2000795 | negative regulation of epithelial cell proliferation involved in lung morphogenesis(GO:2000795) |
0.0 | 0.1 | GO:0042662 | endodermal cell fate determination(GO:0007493) negative regulation of mesodermal cell fate specification(GO:0042662) stem cell fate specification(GO:0048866) cardiac cell fate determination(GO:0060913) |
0.0 | 0.3 | GO:0032570 | response to progesterone(GO:0032570) |
0.0 | 0.4 | GO:0072338 | allantoin metabolic process(GO:0000255) creatinine metabolic process(GO:0046449) cellular lactam metabolic process(GO:0072338) |
0.0 | 0.1 | GO:0080154 | regulation of fertilization(GO:0080154) |
0.0 | 0.4 | GO:0036035 | osteoclast development(GO:0036035) |
0.0 | 0.5 | GO:0016056 | rhodopsin mediated signaling pathway(GO:0016056) protein-chromophore linkage(GO:0018298) |
0.0 | 0.3 | GO:0060024 | rhythmic synaptic transmission(GO:0060024) |
0.0 | 0.1 | GO:1904996 | positive regulation of leukocyte adhesion to vascular endothelial cell(GO:1904996) |
0.0 | 0.5 | GO:0048280 | vesicle fusion with Golgi apparatus(GO:0048280) |
0.0 | 0.0 | GO:0071955 | recycling endosome to Golgi transport(GO:0071955) |
0.0 | 0.5 | GO:2000465 | regulation of glycogen (starch) synthase activity(GO:2000465) |
0.0 | 0.1 | GO:0001983 | baroreceptor response to increased systemic arterial blood pressure(GO:0001983) |
0.0 | 1.1 | GO:0045026 | plasma membrane fusion(GO:0045026) |
0.0 | 0.1 | GO:0006499 | N-terminal protein myristoylation(GO:0006499) |
0.0 | 0.2 | GO:0033031 | positive regulation of neutrophil apoptotic process(GO:0033031) |
0.0 | 0.1 | GO:0050703 | interleukin-1 alpha production(GO:0032610) interleukin-1 alpha secretion(GO:0050703) |
0.0 | 0.1 | GO:0007354 | zygotic determination of anterior/posterior axis, embryo(GO:0007354) |
0.0 | 0.8 | GO:0060219 | camera-type eye photoreceptor cell differentiation(GO:0060219) |
0.0 | 0.4 | GO:0045901 | positive regulation of translational elongation(GO:0045901) |
0.0 | 0.4 | GO:0021796 | cerebral cortex regionalization(GO:0021796) |
0.0 | 0.3 | GO:0042940 | D-amino acid transport(GO:0042940) |
0.0 | 0.1 | GO:0018171 | peptidyl-cysteine oxidation(GO:0018171) |
0.0 | 0.5 | GO:0002726 | positive regulation of T cell cytokine production(GO:0002726) |
0.0 | 0.2 | GO:0071894 | histone H2B conserved C-terminal lysine ubiquitination(GO:0071894) |
0.0 | 0.2 | GO:1900003 | regulation of serine-type endopeptidase activity(GO:1900003) negative regulation of serine-type endopeptidase activity(GO:1900004) regulation of serine-type peptidase activity(GO:1902571) negative regulation of serine-type peptidase activity(GO:1902572) |
0.0 | 0.3 | GO:0010897 | negative regulation of triglyceride catabolic process(GO:0010897) |
0.0 | 0.4 | GO:0006013 | mannose metabolic process(GO:0006013) |
0.0 | 0.3 | GO:0033033 | negative regulation of myeloid cell apoptotic process(GO:0033033) |
0.0 | 0.2 | GO:1904453 | regulation of hydrogen:potassium-exchanging ATPase activity(GO:1904451) positive regulation of hydrogen:potassium-exchanging ATPase activity(GO:1904453) |
0.0 | 0.3 | GO:1902033 | regulation of hematopoietic stem cell proliferation(GO:1902033) |
0.0 | 0.2 | GO:0042938 | dipeptide transport(GO:0042938) |
0.0 | 0.6 | GO:0001780 | neutrophil homeostasis(GO:0001780) |
0.0 | 0.3 | GO:0060767 | epithelial cell proliferation involved in prostate gland development(GO:0060767) regulation of epithelial cell proliferation involved in prostate gland development(GO:0060768) negative regulation of epithelial cell proliferation involved in prostate gland development(GO:0060770) |
0.0 | 0.8 | GO:0021794 | thalamus development(GO:0021794) |
0.0 | 0.5 | GO:0001580 | detection of chemical stimulus involved in sensory perception of bitter taste(GO:0001580) |
0.0 | 0.3 | GO:0061002 | negative regulation of dendritic spine morphogenesis(GO:0061002) |
0.0 | 0.0 | GO:1903588 | negative regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis(GO:1903588) |
0.0 | 0.2 | GO:0032229 | negative regulation of synaptic transmission, GABAergic(GO:0032229) |
0.0 | 0.3 | GO:2000766 | negative regulation of cytoplasmic translation(GO:2000766) |
0.0 | 0.2 | GO:1901525 | negative regulation of macromitophagy(GO:1901525) |
0.0 | 0.1 | GO:0035964 | COPI-coated vesicle budding(GO:0035964) |
0.0 | 1.6 | GO:0006890 | retrograde vesicle-mediated transport, Golgi to ER(GO:0006890) |
0.0 | 0.1 | GO:1900020 | regulation of protein kinase C activity(GO:1900019) positive regulation of protein kinase C activity(GO:1900020) |
0.0 | 0.2 | GO:1900095 | regulation of dosage compensation by inactivation of X chromosome(GO:1900095) |
0.0 | 0.3 | GO:0015961 | diadenosine polyphosphate catabolic process(GO:0015961) |
0.0 | 0.1 | GO:0045409 | negative regulation of interleukin-6 biosynthetic process(GO:0045409) |
0.0 | 0.2 | GO:0038018 | Wnt receptor catabolic process(GO:0038018) |
0.0 | 0.1 | GO:0045919 | positive regulation of cytolysis(GO:0045919) |
0.0 | 0.2 | GO:0035810 | positive regulation of urine volume(GO:0035810) |
0.0 | 0.3 | GO:0035887 | aortic smooth muscle cell differentiation(GO:0035887) |
0.0 | 0.0 | GO:0061010 | gall bladder development(GO:0061010) |
0.0 | 0.1 | GO:0010459 | negative regulation of heart rate(GO:0010459) |
0.0 | 0.2 | GO:0030432 | peristalsis(GO:0030432) |
0.0 | 0.5 | GO:0070995 | NADPH oxidation(GO:0070995) |
0.0 | 0.3 | GO:0071896 | protein localization to adherens junction(GO:0071896) |
0.0 | 0.6 | GO:0016339 | calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0016339) |
0.0 | 0.1 | GO:2000301 | negative regulation of synaptic vesicle exocytosis(GO:2000301) |
0.0 | 0.2 | GO:0030242 | pexophagy(GO:0030242) |
0.0 | 0.8 | GO:1900078 | positive regulation of cellular response to insulin stimulus(GO:1900078) |
0.0 | 0.8 | GO:0051482 | positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G-protein coupled signaling pathway(GO:0051482) |
0.0 | 0.2 | GO:2000189 | positive regulation of cholesterol homeostasis(GO:2000189) |
0.0 | 0.1 | GO:1901896 | protein localization to nuclear pore(GO:0090204) positive regulation of calcium-transporting ATPase activity(GO:1901896) |
0.0 | 0.1 | GO:0044313 | protein K6-linked deubiquitination(GO:0044313) |
0.0 | 0.2 | GO:1901252 | regulation of intracellular transport of viral material(GO:1901252) |
0.0 | 0.1 | GO:0016598 | protein arginylation(GO:0016598) |
0.0 | 0.2 | GO:0042699 | follicle-stimulating hormone signaling pathway(GO:0042699) |
0.0 | 0.1 | GO:0098501 | polynucleotide dephosphorylation(GO:0098501) |
0.0 | 0.1 | GO:1902220 | positive regulation of intrinsic apoptotic signaling pathway in response to osmotic stress(GO:1902220) |
0.0 | 0.1 | GO:0021524 | visceral motor neuron differentiation(GO:0021524) |
0.0 | 0.2 | GO:0034134 | toll-like receptor 2 signaling pathway(GO:0034134) |
0.0 | 0.5 | GO:1901741 | positive regulation of myoblast fusion(GO:1901741) |
0.0 | 0.3 | GO:0043011 | myeloid dendritic cell differentiation(GO:0043011) |
0.0 | 0.2 | GO:0045651 | positive regulation of macrophage differentiation(GO:0045651) |
0.0 | 0.1 | GO:0070245 | positive regulation of thymocyte apoptotic process(GO:0070245) |
0.0 | 0.1 | GO:0014846 | esophagus smooth muscle contraction(GO:0014846) glial cell-derived neurotrophic factor receptor signaling pathway(GO:0035860) regulation of prostatic bud formation(GO:0060685) negative regulation of prostatic bud formation(GO:0060686) |
0.0 | 0.2 | GO:0071830 | chylomicron remnant clearance(GO:0034382) triglyceride-rich lipoprotein particle clearance(GO:0071830) |
0.0 | 0.2 | GO:0031584 | activation of phospholipase D activity(GO:0031584) |
0.0 | 0.2 | GO:0051611 | serotonin uptake(GO:0051610) regulation of serotonin uptake(GO:0051611) |
0.0 | 0.1 | GO:0006420 | arginyl-tRNA aminoacylation(GO:0006420) |
0.0 | 0.3 | GO:2000009 | negative regulation of protein localization to cell surface(GO:2000009) |
0.0 | 0.3 | GO:0008105 | asymmetric protein localization(GO:0008105) |
0.0 | 0.4 | GO:0019934 | cGMP-mediated signaling(GO:0019934) |
0.0 | 0.4 | GO:0060218 | hematopoietic stem cell differentiation(GO:0060218) |
0.0 | 0.3 | GO:0035987 | endodermal cell differentiation(GO:0035987) |
0.0 | 0.1 | GO:0034285 | response to sucrose(GO:0009744) response to disaccharide(GO:0034285) |
0.0 | 0.4 | GO:0097502 | mannosylation(GO:0097502) |
0.0 | 0.4 | GO:0031000 | response to caffeine(GO:0031000) |
0.0 | 0.1 | GO:0070317 | negative regulation of G0 to G1 transition(GO:0070317) |
0.0 | 0.3 | GO:0009396 | folic acid-containing compound biosynthetic process(GO:0009396) |
0.0 | 0.3 | GO:0032516 | positive regulation of phosphoprotein phosphatase activity(GO:0032516) |
0.0 | 0.1 | GO:0090156 | negative regulation of sphingolipid biosynthetic process(GO:0090155) cellular sphingolipid homeostasis(GO:0090156) negative regulation of ceramide biosynthetic process(GO:1900060) |
0.0 | 0.1 | GO:0072014 | proximal tubule development(GO:0072014) |
0.0 | 0.2 | GO:0018242 | protein O-linked glycosylation via serine(GO:0018242) |
0.0 | 0.1 | GO:0060971 | embryonic heart tube left/right pattern formation(GO:0060971) |
0.0 | 0.2 | GO:0051665 | membrane raft localization(GO:0051665) |
0.0 | 0.3 | GO:0071360 | cellular response to exogenous dsRNA(GO:0071360) |
0.0 | 0.2 | GO:0039019 | pronephric nephron development(GO:0039019) |
0.0 | 0.3 | GO:0035092 | sperm chromatin condensation(GO:0035092) |
0.0 | 0.1 | GO:0032095 | regulation of response to food(GO:0032095) |
0.0 | 0.1 | GO:0035166 | post-embryonic hemopoiesis(GO:0035166) |
0.0 | 0.1 | GO:1904170 | regulation of bleb assembly(GO:1904170) |
0.0 | 0.1 | GO:0031268 | pseudopodium organization(GO:0031268) |
0.0 | 0.6 | GO:0031295 | T cell costimulation(GO:0031295) |
0.0 | 0.0 | GO:0051542 | elastin biosynthetic process(GO:0051542) |
0.0 | 0.2 | GO:0016266 | O-glycan processing(GO:0016266) |
0.0 | 0.1 | GO:0007288 | sperm axoneme assembly(GO:0007288) |
0.0 | 0.3 | GO:0045161 | neuronal ion channel clustering(GO:0045161) |
0.0 | 0.1 | GO:0021564 | vagus nerve development(GO:0021564) |
0.0 | 0.4 | GO:0071260 | cellular response to mechanical stimulus(GO:0071260) |
0.0 | 0.2 | GO:2000252 | negative regulation of feeding behavior(GO:2000252) |
0.0 | 0.2 | GO:0019805 | quinolinate biosynthetic process(GO:0019805) |
0.0 | 0.1 | GO:0045085 | negative regulation of interleukin-2 biosynthetic process(GO:0045085) |
0.0 | 0.5 | GO:0051044 | positive regulation of membrane protein ectodomain proteolysis(GO:0051044) |
0.0 | 0.3 | GO:0060346 | bone trabecula formation(GO:0060346) |
0.0 | 0.2 | GO:0060137 | maternal process involved in parturition(GO:0060137) |
0.0 | 0.1 | GO:0010520 | regulation of reciprocal meiotic recombination(GO:0010520) positive regulation of reciprocal meiotic recombination(GO:0010845) |
0.0 | 0.2 | GO:0002693 | positive regulation of cellular extravasation(GO:0002693) |
0.0 | 0.1 | GO:0061144 | alveolar secondary septum development(GO:0061144) |
0.0 | 0.2 | GO:0030382 | sperm mitochondrion organization(GO:0030382) |
0.0 | 0.6 | GO:0006891 | intra-Golgi vesicle-mediated transport(GO:0006891) |
0.0 | 0.3 | GO:2000300 | regulation of synaptic vesicle exocytosis(GO:2000300) |
0.0 | 0.2 | GO:0051014 | actin filament severing(GO:0051014) |
0.0 | 0.2 | GO:0021569 | rhombomere 3 development(GO:0021569) |
0.0 | 0.1 | GO:0071707 | immunoglobulin heavy chain V-D-J recombination(GO:0071707) |
0.0 | 0.1 | GO:0090238 | positive regulation of sphingolipid biosynthetic process(GO:0090154) positive regulation of arachidonic acid secretion(GO:0090238) positive regulation of ceramide biosynthetic process(GO:2000304) |
0.0 | 0.1 | GO:0006995 | cellular response to nitrogen starvation(GO:0006995) cellular response to nitrogen levels(GO:0043562) |
0.0 | 0.3 | GO:0046697 | decidualization(GO:0046697) |
0.0 | 0.1 | GO:0031590 | wybutosine metabolic process(GO:0031590) wybutosine biosynthetic process(GO:0031591) |
0.0 | 0.5 | GO:0051898 | negative regulation of protein kinase B signaling(GO:0051898) |
0.0 | 0.4 | GO:0045332 | phospholipid translocation(GO:0045332) |
0.0 | 0.5 | GO:0006691 | leukotriene metabolic process(GO:0006691) |
0.0 | 0.1 | GO:0045987 | positive regulation of smooth muscle contraction(GO:0045987) |
0.0 | 0.5 | GO:0046688 | response to copper ion(GO:0046688) |
0.0 | 0.2 | GO:0042421 | norepinephrine biosynthetic process(GO:0042421) |
0.0 | 0.1 | GO:0051873 | disruption by host of symbiont cells(GO:0051852) killing by host of symbiont cells(GO:0051873) |
0.0 | 0.1 | GO:2000271 | positive regulation of fibroblast apoptotic process(GO:2000271) |
0.0 | 0.4 | GO:0042347 | negative regulation of NF-kappaB import into nucleus(GO:0042347) |
0.0 | 1.2 | GO:0043392 | negative regulation of DNA binding(GO:0043392) |
0.0 | 0.1 | GO:1901727 | positive regulation of histone deacetylase activity(GO:1901727) |
0.0 | 0.1 | GO:1904959 | regulation of electron carrier activity(GO:1904732) regulation of cytochrome-c oxidase activity(GO:1904959) |
0.0 | 0.5 | GO:0045907 | positive regulation of vasoconstriction(GO:0045907) |
0.0 | 0.2 | GO:0006072 | glycerol-3-phosphate metabolic process(GO:0006072) |
0.0 | 0.1 | GO:0031642 | negative regulation of myelination(GO:0031642) |
0.0 | 0.5 | GO:0030033 | microvillus assembly(GO:0030033) |
0.0 | 0.7 | GO:0032611 | interleukin-1 beta production(GO:0032611) |
0.0 | 0.2 | GO:0006369 | termination of RNA polymerase II transcription(GO:0006369) |
0.0 | 0.1 | GO:0090074 | negative regulation of protein homodimerization activity(GO:0090074) |
0.0 | 0.5 | GO:0038092 | nodal signaling pathway(GO:0038092) |
0.0 | 0.4 | GO:1903963 | arachidonic acid secretion(GO:0050482) arachidonate transport(GO:1903963) |
0.0 | 1.1 | GO:0001836 | release of cytochrome c from mitochondria(GO:0001836) |
0.0 | 0.2 | GO:0002507 | tolerance induction(GO:0002507) |
0.0 | 0.7 | GO:0015914 | phospholipid transport(GO:0015914) |
0.0 | 0.3 | GO:0071712 | ER-associated misfolded protein catabolic process(GO:0071712) |
0.0 | 0.7 | GO:0006783 | heme biosynthetic process(GO:0006783) |
0.0 | 0.3 | GO:0030388 | fructose 1,6-bisphosphate metabolic process(GO:0030388) |
0.0 | 0.3 | GO:0060211 | regulation of nuclear-transcribed mRNA poly(A) tail shortening(GO:0060211) positive regulation of nuclear-transcribed mRNA poly(A) tail shortening(GO:0060213) |
0.0 | 0.3 | GO:0002328 | pro-B cell differentiation(GO:0002328) |
0.0 | 0.1 | GO:0051660 | establishment of centrosome localization(GO:0051660) |
0.0 | 0.1 | GO:0006363 | transcription initiation from RNA polymerase I promoter(GO:0006361) termination of RNA polymerase I transcription(GO:0006363) |
0.0 | 0.2 | GO:0060159 | regulation of dopamine receptor signaling pathway(GO:0060159) |
0.0 | 0.2 | GO:0043374 | CD8-positive, alpha-beta T cell differentiation(GO:0043374) |
0.0 | 0.1 | GO:1901509 | regulation of endothelial tube morphogenesis(GO:1901509) |
0.0 | 0.0 | GO:0003284 | septum primum development(GO:0003284) |
0.0 | 0.5 | GO:0006953 | acute-phase response(GO:0006953) |
0.0 | 0.3 | GO:0019373 | epoxygenase P450 pathway(GO:0019373) |
0.0 | 0.1 | GO:0070164 | adiponectin secretion(GO:0070162) regulation of adiponectin secretion(GO:0070163) negative regulation of adiponectin secretion(GO:0070164) |
0.0 | 0.1 | GO:0071907 | regulation of cilium movement(GO:0003352) regulation of cilium beat frequency(GO:0003356) determination of pancreatic left/right asymmetry(GO:0035469) determination of digestive tract left/right asymmetry(GO:0071907) |
0.0 | 0.4 | GO:0001675 | acrosome assembly(GO:0001675) |
0.0 | 0.1 | GO:0007023 | post-chaperonin tubulin folding pathway(GO:0007023) |
0.0 | 0.3 | GO:0006516 | glycoprotein catabolic process(GO:0006516) |
0.0 | 0.2 | GO:0048312 | intracellular distribution of mitochondria(GO:0048312) |
0.0 | 0.0 | GO:1904879 | positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel(GO:1904879) |
0.0 | 0.6 | GO:0048268 | clathrin coat assembly(GO:0048268) |
0.0 | 0.2 | GO:1904153 | negative regulation of protein exit from endoplasmic reticulum(GO:0070862) negative regulation of retrograde protein transport, ER to cytosol(GO:1904153) |
0.0 | 0.3 | GO:0032793 | positive regulation of CREB transcription factor activity(GO:0032793) |
0.0 | 0.0 | GO:1904457 | positive regulation of neuronal action potential(GO:1904457) |
0.0 | 0.1 | GO:0032460 | negative regulation of protein oligomerization(GO:0032460) |
0.0 | 0.1 | GO:0019355 | nicotinamide nucleotide biosynthetic process from aspartate(GO:0019355) 'de novo' NAD biosynthetic process(GO:0034627) 'de novo' NAD biosynthetic process from aspartate(GO:0034628) |
0.0 | 0.3 | GO:0021895 | cerebral cortex neuron differentiation(GO:0021895) |
0.0 | 0.3 | GO:0033198 | response to ATP(GO:0033198) |
0.0 | 0.1 | GO:0006032 | chitin metabolic process(GO:0006030) chitin catabolic process(GO:0006032) |
0.0 | 0.2 | GO:0030240 | skeletal muscle thin filament assembly(GO:0030240) |
0.0 | 0.2 | GO:0006004 | fucose metabolic process(GO:0006004) |
0.0 | 0.2 | GO:0044068 | modulation by symbiont of host cellular process(GO:0044068) |
0.0 | 0.1 | GO:0032876 | negative regulation of DNA endoreduplication(GO:0032876) |
0.0 | 0.1 | GO:0060124 | positive regulation of growth hormone secretion(GO:0060124) |
0.0 | 0.1 | GO:0043508 | negative regulation of JUN kinase activity(GO:0043508) |
0.0 | 0.2 | GO:0018095 | protein polyglutamylation(GO:0018095) |
0.0 | 0.3 | GO:2000310 | regulation of N-methyl-D-aspartate selective glutamate receptor activity(GO:2000310) |
0.0 | 0.1 | GO:0046007 | negative regulation of activated T cell proliferation(GO:0046007) |
0.0 | 0.0 | GO:0036090 | cleavage furrow ingression(GO:0036090) |
0.0 | 0.1 | GO:0045358 | negative regulation of interferon-beta biosynthetic process(GO:0045358) |
0.0 | 0.1 | GO:0039536 | negative regulation of RIG-I signaling pathway(GO:0039536) |
0.0 | 0.3 | GO:0044804 | nucleophagy(GO:0044804) |
0.0 | 0.1 | GO:0046726 | positive regulation by virus of viral protein levels in host cell(GO:0046726) |
0.0 | 0.5 | GO:2000785 | regulation of autophagosome assembly(GO:2000785) |
0.0 | 0.1 | GO:0030046 | parallel actin filament bundle assembly(GO:0030046) |
0.0 | 0.1 | GO:0034720 | histone H3-K4 demethylation(GO:0034720) |
0.0 | 0.6 | GO:0032012 | ARF protein signal transduction(GO:0032011) regulation of ARF protein signal transduction(GO:0032012) |
0.0 | 0.2 | GO:0046415 | urate metabolic process(GO:0046415) |
0.0 | 0.2 | GO:0014856 | skeletal muscle satellite cell proliferation(GO:0014841) regulation of skeletal muscle satellite cell proliferation(GO:0014842) skeletal muscle cell proliferation(GO:0014856) regulation of skeletal muscle cell proliferation(GO:0014857) |
0.0 | 0.1 | GO:0043553 | negative regulation of phosphatidylinositol 3-kinase activity(GO:0043553) |
0.0 | 0.2 | GO:0002230 | positive regulation of defense response to virus by host(GO:0002230) |
0.0 | 0.1 | GO:1902897 | regulation of postsynaptic density protein 95 clustering(GO:1902897) positive regulation of dendritic spine maintenance(GO:1902952) regulation of transcription from RNA polymerase II promoter by histone modification(GO:1903756) negative regulation of transcription from RNA polymerase II promoter by histone modification(GO:1903758) |
0.0 | 0.0 | GO:2000108 | positive regulation of leukocyte apoptotic process(GO:2000108) |
0.0 | 0.6 | GO:0045576 | mast cell activation(GO:0045576) |
0.0 | 0.1 | GO:0010636 | positive regulation of mitochondrial fusion(GO:0010636) |
0.0 | 0.4 | GO:0033169 | histone H3-K9 demethylation(GO:0033169) |
0.0 | 0.2 | GO:0090209 | negative regulation of triglyceride metabolic process(GO:0090209) |
0.0 | 0.1 | GO:0009972 | cytidine catabolic process(GO:0006216) cytidine deamination(GO:0009972) cytidine metabolic process(GO:0046087) |
0.0 | 0.1 | GO:0090481 | pyrimidine nucleotide-sugar transmembrane transport(GO:0090481) |
0.0 | 0.2 | GO:0032264 | purine nucleotide salvage(GO:0032261) IMP salvage(GO:0032264) |
0.0 | 0.1 | GO:1902167 | positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator(GO:1902167) |
0.0 | 0.1 | GO:0045721 | negative regulation of gluconeogenesis(GO:0045721) |
0.0 | 0.1 | GO:2001015 | negative regulation of skeletal muscle cell differentiation(GO:2001015) |
0.0 | 0.0 | GO:0097066 | response to thyroid hormone(GO:0097066) |
0.0 | 0.1 | GO:0033578 | protein glycosylation in Golgi(GO:0033578) |
0.0 | 0.1 | GO:0046929 | negative regulation of neurotransmitter secretion(GO:0046929) |
0.0 | 0.1 | GO:0021553 | right ventricular cardiac muscle tissue morphogenesis(GO:0003221) olfactory nerve development(GO:0021553) |
0.0 | 0.0 | GO:0060447 | bud outgrowth involved in lung branching(GO:0060447) |
0.0 | 0.1 | GO:0060136 | embryonic process involved in female pregnancy(GO:0060136) |
0.0 | 0.1 | GO:0030035 | microspike assembly(GO:0030035) |
0.0 | 0.3 | GO:0071625 | vocalization behavior(GO:0071625) |
0.0 | 0.3 | GO:0006958 | complement activation, classical pathway(GO:0006958) |
0.0 | 0.2 | GO:0000185 | activation of MAPKKK activity(GO:0000185) |
0.0 | 0.2 | GO:0006614 | SRP-dependent cotranslational protein targeting to membrane(GO:0006614) |
0.0 | 0.0 | GO:0043570 | maintenance of DNA repeat elements(GO:0043570) |
0.0 | 0.1 | GO:0032485 | regulation of Ral protein signal transduction(GO:0032485) |
0.0 | 0.2 | GO:0006829 | zinc II ion transport(GO:0006829) |
0.0 | 0.1 | GO:0071338 | positive regulation of hair follicle cell proliferation(GO:0071338) |
0.0 | 0.1 | GO:0021902 | commitment of neuronal cell to specific neuron type in forebrain(GO:0021902) |
0.0 | 0.2 | GO:0050832 | defense response to fungus(GO:0050832) |
0.0 | 0.1 | GO:0021577 | hindbrain structural organization(GO:0021577) cerebellum structural organization(GO:0021589) lateral motor column neuron migration(GO:0097477) |
0.0 | 0.1 | GO:0030263 | apoptotic chromosome condensation(GO:0030263) |
0.0 | 0.1 | GO:0051715 | cytolysis in other organism(GO:0051715) |
0.0 | 0.1 | GO:0032703 | negative regulation of interleukin-2 production(GO:0032703) |
0.0 | 0.4 | GO:0015893 | drug transport(GO:0015893) |
0.0 | 0.1 | GO:0006684 | sphingomyelin metabolic process(GO:0006684) |
0.0 | 0.1 | GO:0051085 | chaperone mediated protein folding requiring cofactor(GO:0051085) |
0.0 | 0.1 | GO:0033299 | secretion of lysosomal enzymes(GO:0033299) |
0.0 | 0.1 | GO:1904321 | response to forskolin(GO:1904321) cellular response to forskolin(GO:1904322) |
0.0 | 0.4 | GO:0042771 | intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator(GO:0042771) |
0.0 | 0.3 | GO:0060765 | regulation of androgen receptor signaling pathway(GO:0060765) |
0.0 | 0.1 | GO:1990401 | embryonic lung development(GO:1990401) |
0.0 | 0.0 | GO:0017055 | negative regulation of RNA polymerase II transcriptional preinitiation complex assembly(GO:0017055) |
0.0 | 0.1 | GO:0045059 | positive thymic T cell selection(GO:0045059) |
0.0 | 0.1 | GO:0031280 | negative regulation of adenylate cyclase activity(GO:0007194) negative regulation of cyclase activity(GO:0031280) |
0.0 | 0.4 | GO:0034113 | heterotypic cell-cell adhesion(GO:0034113) |
0.0 | 0.1 | GO:0033353 | S-adenosylmethionine cycle(GO:0033353) |
0.0 | 0.1 | GO:0003413 | chondrocyte differentiation involved in endochondral bone morphogenesis(GO:0003413) |
0.0 | 0.1 | GO:0034427 | nuclear-transcribed mRNA catabolic process, exonucleolytic, 3'-5'(GO:0034427) |
0.0 | 0.1 | GO:1902474 | positive regulation of protein localization to synapse(GO:1902474) |
0.0 | 0.1 | GO:0009814 | defense response, incompatible interaction(GO:0009814) defense response to bacterium, incompatible interaction(GO:0009816) regulation of defense response to bacterium, incompatible interaction(GO:1902477) |
0.0 | 0.2 | GO:0099612 | protein localization to axon(GO:0099612) |
0.0 | 0.1 | GO:0045716 | positive regulation of low-density lipoprotein particle receptor biosynthetic process(GO:0045716) |
0.0 | 0.1 | GO:0042373 | vitamin K metabolic process(GO:0042373) |
0.0 | 0.1 | GO:0097428 | protein maturation by iron-sulfur cluster transfer(GO:0097428) |
0.0 | 0.2 | GO:0097435 | fibril organization(GO:0097435) |
0.0 | 0.5 | GO:0007193 | adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway(GO:0007193) |
0.0 | 0.1 | GO:0002335 | mature B cell differentiation(GO:0002335) |
0.0 | 0.0 | GO:0010286 | heat acclimation(GO:0010286) |
0.0 | 0.5 | GO:1901998 | toxin transport(GO:1901998) |
0.0 | 0.0 | GO:0006692 | prostanoid metabolic process(GO:0006692) prostaglandin metabolic process(GO:0006693) |
0.0 | 0.2 | GO:0034587 | piRNA metabolic process(GO:0034587) |
0.0 | 0.2 | GO:0052697 | flavonoid glucuronidation(GO:0052696) xenobiotic glucuronidation(GO:0052697) |
0.0 | 0.2 | GO:0002089 | lens morphogenesis in camera-type eye(GO:0002089) |
0.0 | 0.8 | GO:0038083 | peptidyl-tyrosine autophosphorylation(GO:0038083) |
0.0 | 0.1 | GO:0030948 | negative regulation of vascular endothelial growth factor receptor signaling pathway(GO:0030948) |
0.0 | 0.1 | GO:0044253 | positive regulation of collagen metabolic process(GO:0010714) positive regulation of collagen biosynthetic process(GO:0032967) positive regulation of multicellular organismal metabolic process(GO:0044253) |
0.0 | 0.0 | GO:0006553 | lysine metabolic process(GO:0006553) |
0.0 | 0.0 | GO:0060440 | trachea formation(GO:0060440) regulation of Golgi inheritance(GO:0090170) |
0.0 | 0.1 | GO:0006700 | C21-steroid hormone biosynthetic process(GO:0006700) |
0.0 | 0.2 | GO:0042755 | eating behavior(GO:0042755) |
0.0 | 0.2 | GO:0048672 | positive regulation of collateral sprouting(GO:0048672) |
0.0 | 0.1 | GO:0014051 | gamma-aminobutyric acid secretion(GO:0014051) gamma-aminobutyric acid transport(GO:0015812) |
0.0 | 0.0 | GO:1990167 | protein K27-linked deubiquitination(GO:1990167) |
0.0 | 0.5 | GO:0007200 | phospholipase C-activating G-protein coupled receptor signaling pathway(GO:0007200) |
0.0 | 0.1 | GO:0006654 | phosphatidic acid biosynthetic process(GO:0006654) |
0.0 | 0.1 | GO:1902303 | negative regulation of potassium ion export(GO:1902303) |
0.0 | 0.1 | GO:1904528 | regulation of microtubule plus-end binding(GO:1903031) positive regulation of microtubule plus-end binding(GO:1903033) regulation of microtubule binding(GO:1904526) positive regulation of microtubule binding(GO:1904528) |
0.0 | 0.1 | GO:0006646 | phosphatidylethanolamine biosynthetic process(GO:0006646) |
0.0 | 0.1 | GO:0006681 | galactosylceramide metabolic process(GO:0006681) |
0.0 | 0.1 | GO:0070966 | nuclear-transcribed mRNA catabolic process, no-go decay(GO:0070966) |
0.0 | 0.1 | GO:1904707 | positive regulation of vascular smooth muscle cell proliferation(GO:1904707) |
0.0 | 0.1 | GO:0001712 | ectodermal cell fate commitment(GO:0001712) |
0.0 | 0.1 | GO:0006907 | pinocytosis(GO:0006907) |
0.0 | 0.3 | GO:0030903 | notochord development(GO:0030903) |
0.0 | 0.0 | GO:0001957 | intramembranous ossification(GO:0001957) direct ossification(GO:0036072) |
0.0 | 0.0 | GO:0010896 | regulation of triglyceride catabolic process(GO:0010896) |
0.0 | 0.1 | GO:0002026 | regulation of the force of heart contraction(GO:0002026) |
0.0 | 0.1 | GO:0072498 | embryonic skeletal joint development(GO:0072498) |
0.0 | 0.2 | GO:0060444 | branching involved in mammary gland duct morphogenesis(GO:0060444) |
0.0 | 0.2 | GO:0034260 | negative regulation of GTPase activity(GO:0034260) |
0.0 | 0.1 | GO:0016446 | somatic hypermutation of immunoglobulin genes(GO:0016446) |
0.0 | 0.0 | GO:0014916 | regulation of lung blood pressure(GO:0014916) negative regulation of cell proliferation involved in heart morphogenesis(GO:2000137) |
0.0 | 0.2 | GO:0032897 | negative regulation of viral transcription(GO:0032897) |
0.0 | 0.0 | GO:0060825 | fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation(GO:0060825) regulation of fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation(GO:2000313) |
0.0 | 0.0 | GO:0097374 | sensory neuron axon guidance(GO:0097374) |
0.0 | 0.1 | GO:0016557 | peroxisome membrane biogenesis(GO:0016557) |
0.0 | 0.0 | GO:0097105 | presynaptic membrane assembly(GO:0097105) |
0.0 | 0.0 | GO:0042448 | progesterone metabolic process(GO:0042448) |
0.0 | 0.2 | GO:0000272 | polysaccharide catabolic process(GO:0000272) glycogen catabolic process(GO:0005980) glucan catabolic process(GO:0009251) cellular polysaccharide catabolic process(GO:0044247) |
0.0 | 0.1 | GO:0070070 | proton-transporting V-type ATPase complex assembly(GO:0070070) vacuolar proton-transporting V-type ATPase complex assembly(GO:0070072) |
0.0 | 0.1 | GO:0042744 | hydrogen peroxide catabolic process(GO:0042744) |
0.0 | 0.1 | GO:0002091 | negative regulation of receptor internalization(GO:0002091) |
0.0 | 0.1 | GO:0017196 | N-terminal peptidyl-methionine acetylation(GO:0017196) |
0.0 | 0.4 | GO:0042733 | embryonic digit morphogenesis(GO:0042733) |
0.0 | 0.1 | GO:0031087 | deadenylation-independent decapping of nuclear-transcribed mRNA(GO:0031087) |
0.0 | 0.0 | GO:0006659 | phosphatidylserine biosynthetic process(GO:0006659) |
0.0 | 0.2 | GO:0050909 | sensory perception of taste(GO:0050909) |
0.0 | 0.0 | GO:0007567 | parturition(GO:0007567) |
0.0 | 0.1 | GO:0090527 | actin filament reorganization(GO:0090527) |
0.0 | 0.0 | GO:0002232 | leukocyte chemotaxis involved in inflammatory response(GO:0002232) regulation of acute inflammatory response to non-antigenic stimulus(GO:0002877) |
0.0 | 0.0 | GO:0015760 | hexose phosphate transport(GO:0015712) glucose-6-phosphate transport(GO:0015760) |
0.0 | 0.2 | GO:0050732 | negative regulation of peptidyl-tyrosine phosphorylation(GO:0050732) |
0.0 | 0.1 | GO:0033327 | Leydig cell differentiation(GO:0033327) |
0.0 | 0.1 | GO:0019835 | cytolysis(GO:0019835) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.5 | 5.3 | GO:0043020 | NADPH oxidase complex(GO:0043020) |
0.3 | 3.4 | GO:0042571 | immunoglobulin complex, circulating(GO:0042571) |
0.3 | 2.0 | GO:0046696 | lipopolysaccharide receptor complex(GO:0046696) |
0.3 | 1.1 | GO:0097169 | AIM2 inflammasome complex(GO:0097169) |
0.2 | 1.0 | GO:1902636 | kinociliary basal body(GO:1902636) |
0.2 | 2.0 | GO:0042105 | alpha-beta T cell receptor complex(GO:0042105) |
0.2 | 1.8 | GO:0032937 | SREBP-SCAP-Insig complex(GO:0032937) |
0.2 | 0.7 | GO:0044299 | C-fiber(GO:0044299) |
0.2 | 0.9 | GO:0034687 | integrin alphaL-beta2 complex(GO:0034687) |
0.2 | 2.7 | GO:0072687 | meiotic spindle(GO:0072687) |
0.2 | 2.6 | GO:0031254 | uropod(GO:0001931) cell trailing edge(GO:0031254) |
0.2 | 0.6 | GO:0034666 | integrin alpha2-beta1 complex(GO:0034666) |
0.2 | 0.6 | GO:0044393 | microspike(GO:0044393) |
0.2 | 0.6 | GO:0005588 | collagen type V trimer(GO:0005588) |
0.2 | 0.8 | GO:0033162 | melanosome membrane(GO:0033162) chitosome(GO:0045009) |
0.2 | 0.5 | GO:0005832 | chaperonin-containing T-complex(GO:0005832) |
0.2 | 0.9 | GO:0030670 | phagocytic vesicle membrane(GO:0030670) |
0.2 | 0.2 | GO:0098830 | presynaptic endosome(GO:0098830) |
0.1 | 0.4 | GO:0043625 | delta DNA polymerase complex(GO:0043625) |
0.1 | 0.4 | GO:0070381 | endosome to plasma membrane transport vesicle(GO:0070381) |
0.1 | 1.7 | GO:0043219 | lateral loop(GO:0043219) |
0.1 | 0.9 | GO:0016012 | sarcoglycan complex(GO:0016012) |
0.1 | 0.6 | GO:0005826 | actomyosin contractile ring(GO:0005826) |
0.1 | 0.5 | GO:0071953 | elastic fiber(GO:0071953) |
0.1 | 0.2 | GO:0070939 | Dsl1p complex(GO:0070939) |
0.1 | 0.5 | GO:0031092 | platelet alpha granule membrane(GO:0031092) |
0.1 | 2.8 | GO:0001891 | phagocytic cup(GO:0001891) |
0.1 | 0.3 | GO:0032783 | ELL-EAF complex(GO:0032783) |
0.1 | 0.6 | GO:0031680 | G-protein beta/gamma-subunit complex(GO:0031680) |
0.1 | 0.4 | GO:0008282 | ATP-sensitive potassium channel complex(GO:0008282) |
0.1 | 0.4 | GO:0016222 | procollagen-proline 4-dioxygenase complex(GO:0016222) |
0.1 | 0.3 | GO:0070195 | growth hormone receptor complex(GO:0070195) |
0.1 | 5.3 | GO:0001772 | immunological synapse(GO:0001772) |
0.1 | 0.4 | GO:0098888 | extrinsic component of presynaptic membrane(GO:0098888) |
0.1 | 0.4 | GO:0097381 | photoreceptor disc membrane(GO:0097381) |
0.1 | 0.4 | GO:0002081 | inner acrosomal membrane(GO:0002079) outer acrosomal membrane(GO:0002081) |
0.1 | 0.6 | GO:0005828 | kinetochore microtubule(GO:0005828) |
0.1 | 0.7 | GO:0098554 | cytoplasmic side of endoplasmic reticulum membrane(GO:0098554) |
0.1 | 0.4 | GO:0034365 | discoidal high-density lipoprotein particle(GO:0034365) |
0.1 | 0.3 | GO:0005610 | laminin-5 complex(GO:0005610) |
0.1 | 0.5 | GO:0044305 | calyx of Held(GO:0044305) |
0.1 | 0.7 | GO:0033093 | Weibel-Palade body(GO:0033093) |
0.1 | 0.5 | GO:0032591 | dendritic spine membrane(GO:0032591) |
0.1 | 0.5 | GO:0042101 | T cell receptor complex(GO:0042101) |
0.1 | 0.6 | GO:0005785 | signal recognition particle receptor complex(GO:0005785) |
0.1 | 0.5 | GO:0005796 | Golgi lumen(GO:0005796) |
0.1 | 0.2 | GO:0038045 | large latent transforming growth factor-beta complex(GO:0038045) |
0.1 | 0.2 | GO:0032280 | symmetric synapse(GO:0032280) |
0.1 | 0.8 | GO:0044300 | cerebellar mossy fiber(GO:0044300) |
0.1 | 1.7 | GO:0016327 | apicolateral plasma membrane(GO:0016327) |
0.1 | 0.8 | GO:0042622 | photoreceptor outer segment membrane(GO:0042622) |
0.1 | 0.4 | GO:1903439 | calcitonin family receptor complex(GO:1903439) amylin receptor complex(GO:1903440) |
0.1 | 0.2 | GO:0034684 | integrin alphav-beta5 complex(GO:0034684) |
0.1 | 0.7 | GO:0045179 | apical cortex(GO:0045179) |
0.1 | 0.2 | GO:0033596 | TSC1-TSC2 complex(GO:0033596) |
0.1 | 0.4 | GO:0019815 | B cell receptor complex(GO:0019815) |
0.1 | 2.2 | GO:0098636 | protein complex involved in cell adhesion(GO:0098636) |
0.1 | 0.3 | GO:0070826 | paraferritin complex(GO:0070826) |
0.1 | 0.4 | GO:0044214 | spanning component of plasma membrane(GO:0044214) spanning component of membrane(GO:0089717) |
0.1 | 0.3 | GO:0005944 | phosphatidylinositol 3-kinase complex, class IB(GO:0005944) |
0.1 | 0.2 | GO:0099631 | postsynaptic endocytic zone cytoplasmic component(GO:0099631) |
0.1 | 1.5 | GO:0016581 | NuRD complex(GO:0016581) CHD-type complex(GO:0090545) |
0.1 | 0.5 | GO:0044233 | ER-mitochondrion membrane contact site(GO:0044233) |
0.1 | 0.9 | GO:0017119 | Golgi transport complex(GO:0017119) |
0.1 | 1.0 | GO:0031618 | nuclear pericentric heterochromatin(GO:0031618) |
0.1 | 0.2 | GO:0070557 | PCNA-p21 complex(GO:0070557) |
0.1 | 0.6 | GO:0071141 | SMAD protein complex(GO:0071141) |
0.1 | 0.5 | GO:0061689 | tricellular tight junction(GO:0061689) |
0.1 | 0.7 | GO:0036157 | outer dynein arm(GO:0036157) |
0.1 | 0.4 | GO:0097342 | ripoptosome(GO:0097342) |
0.1 | 1.1 | GO:0005922 | connexon complex(GO:0005922) |
0.1 | 1.2 | GO:0012507 | ER to Golgi transport vesicle membrane(GO:0012507) |
0.1 | 0.2 | GO:0030121 | AP-1 adaptor complex(GO:0030121) |
0.1 | 0.4 | GO:0005641 | nuclear envelope lumen(GO:0005641) |
0.1 | 0.6 | GO:0005766 | primary lysosome(GO:0005766) azurophil granule(GO:0042582) |
0.1 | 0.4 | GO:0005964 | phosphorylase kinase complex(GO:0005964) |
0.1 | 2.4 | GO:0048786 | presynaptic active zone(GO:0048786) |
0.1 | 1.1 | GO:0033017 | sarcoplasmic reticulum membrane(GO:0033017) |
0.1 | 0.5 | GO:0071664 | beta-catenin-TCF7L2 complex(GO:0070369) catenin-TCF7L2 complex(GO:0071664) |
0.1 | 0.4 | GO:0033263 | CORVET complex(GO:0033263) |
0.0 | 0.9 | GO:0005605 | basal lamina(GO:0005605) |
0.0 | 0.8 | GO:0036057 | filtration diaphragm(GO:0036056) slit diaphragm(GO:0036057) |
0.0 | 0.6 | GO:0042613 | MHC class II protein complex(GO:0042613) |
0.0 | 0.4 | GO:0042567 | insulin-like growth factor ternary complex(GO:0042567) |
0.0 | 0.3 | GO:0032807 | DNA-dependent protein kinase-DNA ligase 4 complex(GO:0005958) DNA ligase IV complex(GO:0032807) |
0.0 | 1.1 | GO:0034364 | high-density lipoprotein particle(GO:0034364) |
0.0 | 0.2 | GO:0005833 | hemoglobin complex(GO:0005833) |
0.0 | 0.1 | GO:0055087 | Ski complex(GO:0055087) |
0.0 | 0.2 | GO:0031084 | BLOC-2 complex(GO:0031084) |
0.0 | 0.4 | GO:0090533 | cation-transporting ATPase complex(GO:0090533) |
0.0 | 0.6 | GO:0031209 | SCAR complex(GO:0031209) |
0.0 | 0.2 | GO:0097574 | lateral part of cell(GO:0097574) basolateral part of cell(GO:1990794) rod bipolar cell terminal bouton(GO:1990795) photoreceptor cell terminal bouton(GO:1990796) |
0.0 | 0.2 | GO:1990769 | proximal neuron projection(GO:1990769) |
0.0 | 0.9 | GO:0097225 | sperm midpiece(GO:0097225) |
0.0 | 1.4 | GO:0000788 | nuclear nucleosome(GO:0000788) |
0.0 | 1.8 | GO:0045335 | phagocytic vesicle(GO:0045335) |
0.0 | 1.1 | GO:0030057 | desmosome(GO:0030057) |
0.0 | 0.1 | GO:0016011 | dystroglycan complex(GO:0016011) |
0.0 | 0.8 | GO:0044224 | juxtaparanode region of axon(GO:0044224) |
0.0 | 0.3 | GO:0031232 | extrinsic component of external side of plasma membrane(GO:0031232) |
0.0 | 1.1 | GO:0000407 | pre-autophagosomal structure(GO:0000407) |
0.0 | 0.1 | GO:0016939 | kinesin II complex(GO:0016939) |
0.0 | 0.3 | GO:0031143 | pseudopodium(GO:0031143) |
0.0 | 0.9 | GO:0071782 | endoplasmic reticulum tubular network(GO:0071782) |
0.0 | 0.1 | GO:0031510 | SUMO activating enzyme complex(GO:0031510) |
0.0 | 0.1 | GO:1990730 | VCP-NSFL1C complex(GO:1990730) |
0.0 | 0.3 | GO:0048500 | signal recognition particle(GO:0048500) |
0.0 | 0.1 | GO:0000802 | transverse filament(GO:0000802) |
0.0 | 0.3 | GO:0005579 | membrane attack complex(GO:0005579) |
0.0 | 10.1 | GO:0009897 | external side of plasma membrane(GO:0009897) |
0.0 | 0.6 | GO:0046658 | anchored component of plasma membrane(GO:0046658) |
0.0 | 0.1 | GO:0036488 | CHOP-C/EBP complex(GO:0036488) |
0.0 | 0.3 | GO:0005787 | signal peptidase complex(GO:0005787) |
0.0 | 3.0 | GO:0072562 | blood microparticle(GO:0072562) |
0.0 | 0.1 | GO:0020018 | ciliary pocket(GO:0020016) ciliary pocket membrane(GO:0020018) |
0.0 | 0.8 | GO:0097038 | perinuclear endoplasmic reticulum(GO:0097038) |
0.0 | 0.5 | GO:0030008 | TRAPP complex(GO:0030008) |
0.0 | 0.4 | GO:0032433 | filopodium tip(GO:0032433) |
0.0 | 0.2 | GO:0097227 | sperm annulus(GO:0097227) |
0.0 | 0.5 | GO:0060293 | P granule(GO:0043186) pole plasm(GO:0045495) germ plasm(GO:0060293) |
0.0 | 0.1 | GO:0030905 | retromer, tubulation complex(GO:0030905) |
0.0 | 0.1 | GO:0097443 | sorting endosome(GO:0097443) |
0.0 | 0.6 | GO:0035253 | ciliary rootlet(GO:0035253) |
0.0 | 0.2 | GO:0097444 | spine apparatus(GO:0097444) |
0.0 | 0.2 | GO:0097197 | tetraspanin-enriched microdomain(GO:0097197) |
0.0 | 0.7 | GO:0042470 | melanosome(GO:0042470) pigment granule(GO:0048770) |
0.0 | 0.1 | GO:0009331 | glycerol-3-phosphate dehydrogenase complex(GO:0009331) |
0.0 | 0.1 | GO:1990667 | PCSK9-AnxA2 complex(GO:1990667) |
0.0 | 0.2 | GO:0090543 | Flemming body(GO:0090543) |
0.0 | 0.5 | GO:0042588 | zymogen granule(GO:0042588) |
0.0 | 0.1 | GO:0042584 | chromaffin granule membrane(GO:0042584) |
0.0 | 1.4 | GO:0005776 | autophagosome(GO:0005776) |
0.0 | 0.2 | GO:0072379 | BAT3 complex(GO:0071818) ER membrane insertion complex(GO:0072379) |
0.0 | 0.1 | GO:0035339 | SPOTS complex(GO:0035339) |
0.0 | 0.1 | GO:0000308 | cytoplasmic cyclin-dependent protein kinase holoenzyme complex(GO:0000308) |
0.0 | 1.2 | GO:0005834 | heterotrimeric G-protein complex(GO:0005834) |
0.0 | 0.4 | GO:0005639 | integral component of nuclear inner membrane(GO:0005639) intrinsic component of nuclear inner membrane(GO:0031229) |
0.0 | 0.1 | GO:0044232 | organelle membrane contact site(GO:0044232) |
0.0 | 0.4 | GO:0002199 | zona pellucida receptor complex(GO:0002199) |
0.0 | 0.4 | GO:0017146 | NMDA selective glutamate receptor complex(GO:0017146) |
0.0 | 0.7 | GO:0030673 | axolemma(GO:0030673) |
0.0 | 0.1 | GO:0070419 | nonhomologous end joining complex(GO:0070419) |
0.0 | 0.2 | GO:0000815 | ESCRT III complex(GO:0000815) |
0.0 | 0.5 | GO:0000930 | gamma-tubulin complex(GO:0000930) |
0.0 | 0.7 | GO:0005779 | integral component of peroxisomal membrane(GO:0005779) |
0.0 | 0.4 | GO:0048188 | Set1C/COMPASS complex(GO:0048188) |
0.0 | 0.8 | GO:0005801 | cis-Golgi network(GO:0005801) |
0.0 | 0.2 | GO:0031527 | filopodium membrane(GO:0031527) |
0.0 | 0.1 | GO:0043512 | inhibin A complex(GO:0043512) |
0.0 | 0.1 | GO:0097543 | ciliary inversin compartment(GO:0097543) |
0.0 | 0.1 | GO:0071439 | clathrin complex(GO:0071439) |
0.0 | 0.3 | GO:0031315 | extrinsic component of mitochondrial outer membrane(GO:0031315) |
0.0 | 27.9 | GO:0005615 | extracellular space(GO:0005615) |
0.0 | 1.0 | GO:0031901 | early endosome membrane(GO:0031901) |
0.0 | 0.0 | GO:1990907 | beta-catenin-TCF complex(GO:1990907) |
0.0 | 0.2 | GO:0016342 | catenin complex(GO:0016342) |
0.0 | 0.9 | GO:0030173 | integral component of Golgi membrane(GO:0030173) |
0.0 | 0.1 | GO:1990462 | omegasome(GO:1990462) |
0.0 | 0.2 | GO:0034464 | BBSome(GO:0034464) |
0.0 | 0.3 | GO:0070971 | endoplasmic reticulum exit site(GO:0070971) |
0.0 | 0.3 | GO:0030285 | integral component of synaptic vesicle membrane(GO:0030285) intrinsic component of synaptic vesicle membrane(GO:0098563) |
0.0 | 1.5 | GO:0097014 | axoneme(GO:0005930) ciliary plasm(GO:0097014) |
0.0 | 0.1 | GO:0000127 | transcription factor TFIIIC complex(GO:0000127) |
0.0 | 1.5 | GO:0031234 | extrinsic component of cytoplasmic side of plasma membrane(GO:0031234) |
0.0 | 0.2 | GO:0000974 | Prp19 complex(GO:0000974) |
0.0 | 0.3 | GO:0071564 | npBAF complex(GO:0071564) |
0.0 | 0.1 | GO:0032437 | cuticular plate(GO:0032437) |
0.0 | 0.6 | GO:0031985 | Golgi cisterna(GO:0031985) |
0.0 | 0.0 | GO:0044316 | cone cell pedicle(GO:0044316) |
0.0 | 0.1 | GO:0033269 | internode region of axon(GO:0033269) |
0.0 | 0.2 | GO:0072546 | ER membrane protein complex(GO:0072546) |
0.0 | 0.2 | GO:0032426 | stereocilium tip(GO:0032426) |
0.0 | 0.0 | GO:0044614 | nuclear pore cytoplasmic filaments(GO:0044614) |
0.0 | 0.1 | GO:1990131 | Gtr1-Gtr2 GTPase complex(GO:1990131) |
0.0 | 0.1 | GO:0031466 | Cul5-RING ubiquitin ligase complex(GO:0031466) |
0.0 | 0.4 | GO:0005793 | endoplasmic reticulum-Golgi intermediate compartment(GO:0005793) |
0.0 | 0.0 | GO:0033257 | Bcl3/NF-kappaB2 complex(GO:0033257) |
0.0 | 0.1 | GO:0000322 | storage vacuole(GO:0000322) |
0.0 | 1.0 | GO:0019005 | SCF ubiquitin ligase complex(GO:0019005) |
0.0 | 0.1 | GO:0005614 | interstitial matrix(GO:0005614) |
0.0 | 0.1 | GO:1990393 | 3M complex(GO:1990393) |
0.0 | 0.5 | GO:0005902 | microvillus(GO:0005902) |
0.0 | 2.4 | GO:0045121 | membrane raft(GO:0045121) membrane microdomain(GO:0098857) |
0.0 | 0.2 | GO:0000124 | SAGA complex(GO:0000124) |
0.0 | 0.2 | GO:0005795 | Golgi stack(GO:0005795) |
0.0 | 0.1 | GO:0036038 | MKS complex(GO:0036038) |
0.0 | 0.7 | GO:0016459 | myosin complex(GO:0016459) |
0.0 | 0.1 | GO:0001527 | microfibril(GO:0001527) fibril(GO:0043205) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.8 | 6.4 | GO:0035662 | Toll-like receptor 4 binding(GO:0035662) |
0.6 | 1.8 | GO:0035717 | chemokine (C-C motif) ligand 7 binding(GO:0035717) |
0.5 | 4.9 | GO:0016176 | superoxide-generating NADPH oxidase activator activity(GO:0016176) |
0.4 | 0.4 | GO:0031726 | CCR1 chemokine receptor binding(GO:0031726) |
0.4 | 1.3 | GO:0031728 | CCR3 chemokine receptor binding(GO:0031728) |
0.4 | 1.1 | GO:0004024 | alcohol dehydrogenase activity, zinc-dependent(GO:0004024) |
0.3 | 1.0 | GO:0004974 | leukotriene receptor activity(GO:0004974) |
0.3 | 2.3 | GO:0005001 | transmembrane receptor protein tyrosine phosphatase activity(GO:0005001) transmembrane receptor protein phosphatase activity(GO:0019198) |
0.3 | 0.8 | GO:0035650 | AP-1 adaptor complex binding(GO:0035650) AP-3 adaptor complex binding(GO:0035651) |
0.3 | 1.1 | GO:0032422 | purine-rich negative regulatory element binding(GO:0032422) |
0.3 | 1.6 | GO:0097001 | ceramide binding(GO:0097001) |
0.3 | 9.7 | GO:0008009 | chemokine activity(GO:0008009) |
0.3 | 1.3 | GO:0004505 | phenylalanine 4-monooxygenase activity(GO:0004505) |
0.3 | 1.0 | GO:0004667 | prostaglandin-D synthase activity(GO:0004667) |
0.3 | 1.5 | GO:0071723 | lipopeptide binding(GO:0071723) |
0.2 | 4.4 | GO:0034987 | immunoglobulin receptor binding(GO:0034987) |
0.2 | 1.6 | GO:0004351 | glutamate decarboxylase activity(GO:0004351) |
0.2 | 1.2 | GO:0042610 | CD8 receptor binding(GO:0042610) |
0.2 | 0.7 | GO:0001042 | RNA polymerase I core binding(GO:0001042) |
0.2 | 0.7 | GO:0005128 | erythropoietin receptor binding(GO:0005128) |
0.2 | 0.9 | GO:0030369 | ICAM-3 receptor activity(GO:0030369) |
0.2 | 0.9 | GO:0016230 | sphingomyelin phosphodiesterase activator activity(GO:0016230) |
0.2 | 1.5 | GO:0008241 | peptidyl-dipeptidase activity(GO:0008241) |
0.2 | 1.5 | GO:0005166 | neurotrophin p75 receptor binding(GO:0005166) |
0.2 | 0.4 | GO:0070506 | high-density lipoprotein particle receptor activity(GO:0070506) |
0.2 | 1.8 | GO:0003810 | protein-glutamine gamma-glutamyltransferase activity(GO:0003810) |
0.2 | 0.6 | GO:0035500 | MH2 domain binding(GO:0035500) |
0.2 | 0.6 | GO:0033829 | O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase activity(GO:0033829) |
0.2 | 0.4 | GO:0031711 | bradykinin receptor binding(GO:0031711) |
0.2 | 1.5 | GO:0019158 | fructokinase activity(GO:0008865) mannokinase activity(GO:0019158) |
0.2 | 0.9 | GO:0001875 | lipopolysaccharide receptor activity(GO:0001875) |
0.2 | 0.5 | GO:0017082 | mineralocorticoid receptor activity(GO:0017082) |
0.2 | 0.5 | GO:0071568 | UFM1 transferase activity(GO:0071568) |
0.2 | 0.7 | GO:0030023 | extracellular matrix constituent conferring elasticity(GO:0030023) |
0.2 | 1.0 | GO:0002046 | opsin binding(GO:0002046) |
0.2 | 0.7 | GO:0004090 | carbonyl reductase (NADPH) activity(GO:0004090) |
0.2 | 0.2 | GO:0045118 | azole transporter activity(GO:0045118) |
0.2 | 0.6 | GO:0005008 | hepatocyte growth factor-activated receptor activity(GO:0005008) |
0.2 | 1.3 | GO:0035727 | lysophosphatidic acid binding(GO:0035727) |
0.2 | 1.2 | GO:0033691 | sialic acid binding(GO:0033691) |
0.2 | 1.7 | GO:0001609 | G-protein coupled adenosine receptor activity(GO:0001609) |
0.2 | 0.5 | GO:0001565 | phorbol ester receptor activity(GO:0001565) non-kinase phorbol ester receptor activity(GO:0001566) |
0.1 | 0.4 | GO:0004711 | ribosomal protein S6 kinase activity(GO:0004711) |
0.1 | 0.4 | GO:0015140 | malate transmembrane transporter activity(GO:0015140) |
0.1 | 0.3 | GO:0070915 | lysophosphatidic acid receptor activity(GO:0070915) |
0.1 | 1.2 | GO:0032564 | dATP binding(GO:0032564) |
0.1 | 0.3 | GO:0035373 | chondroitin sulfate proteoglycan binding(GO:0035373) |
0.1 | 0.4 | GO:0035575 | histone demethylase activity (H4-K20 specific)(GO:0035575) |
0.1 | 1.1 | GO:0070290 | N-acylphosphatidylethanolamine-specific phospholipase D activity(GO:0070290) |
0.1 | 0.5 | GO:0070976 | TIR domain binding(GO:0070976) |
0.1 | 1.7 | GO:0019865 | immunoglobulin binding(GO:0019865) |
0.1 | 0.4 | GO:0005157 | macrophage colony-stimulating factor receptor binding(GO:0005157) |
0.1 | 1.0 | GO:0047498 | calcium-dependent phospholipase A2 activity(GO:0047498) |
0.1 | 0.4 | GO:1990050 | phosphatidic acid transporter activity(GO:1990050) |
0.1 | 0.5 | GO:0051185 | coenzyme transporter activity(GO:0051185) |
0.1 | 0.5 | GO:0001847 | opsonin receptor activity(GO:0001847) |
0.1 | 0.5 | GO:0004966 | galanin receptor activity(GO:0004966) |
0.1 | 0.6 | GO:0070568 | guanylyltransferase activity(GO:0070568) |
0.1 | 0.9 | GO:0005094 | Rho GDP-dissociation inhibitor activity(GO:0005094) |
0.1 | 0.5 | GO:0004921 | interleukin-11 receptor activity(GO:0004921) interleukin-11 binding(GO:0019970) |
0.1 | 0.6 | GO:0072542 | protein phosphatase activator activity(GO:0072542) |
0.1 | 0.8 | GO:0004499 | N,N-dimethylaniline monooxygenase activity(GO:0004499) |
0.1 | 0.4 | GO:0016175 | superoxide-generating NADPH oxidase activity(GO:0016175) |
0.1 | 0.3 | GO:0004903 | growth hormone receptor activity(GO:0004903) |
0.1 | 0.5 | GO:0015189 | L-lysine transmembrane transporter activity(GO:0015189) |
0.1 | 1.1 | GO:0043262 | adenosine-diphosphatase activity(GO:0043262) |
0.1 | 0.3 | GO:0003845 | 11-beta-hydroxysteroid dehydrogenase [NAD(P)] activity(GO:0003845) |
0.1 | 0.6 | GO:0005173 | stem cell factor receptor binding(GO:0005173) |
0.1 | 0.4 | GO:0004705 | JUN kinase activity(GO:0004705) SAP kinase activity(GO:0016909) |
0.1 | 1.2 | GO:0051525 | NFAT protein binding(GO:0051525) |
0.1 | 0.3 | GO:0004069 | L-aspartate:2-oxoglutarate aminotransferase activity(GO:0004069) |
0.1 | 0.4 | GO:0019136 | deoxynucleoside kinase activity(GO:0019136) |
0.1 | 0.4 | GO:0047389 | glycerophosphocholine phosphodiesterase activity(GO:0047389) |
0.1 | 0.3 | GO:0022865 | transmembrane electron transfer carrier(GO:0022865) |
0.1 | 0.9 | GO:0001608 | G-protein coupled nucleotide receptor activity(GO:0001608) G-protein coupled purinergic nucleotide receptor activity(GO:0045028) |
0.1 | 0.4 | GO:0046923 | ER retention sequence binding(GO:0046923) |
0.1 | 1.0 | GO:0098821 | BMP receptor activity(GO:0098821) |
0.1 | 0.4 | GO:0019976 | interleukin-2 binding(GO:0019976) |
0.1 | 0.9 | GO:0001730 | 2'-5'-oligoadenylate synthetase activity(GO:0001730) |
0.1 | 3.4 | GO:0043394 | proteoglycan binding(GO:0043394) |
0.1 | 0.4 | GO:0005415 | nucleoside:sodium symporter activity(GO:0005415) |
0.1 | 0.4 | GO:0004656 | procollagen-proline 4-dioxygenase activity(GO:0004656) procollagen-proline dioxygenase activity(GO:0019798) |
0.1 | 2.8 | GO:0005385 | zinc ion transmembrane transporter activity(GO:0005385) |
0.1 | 0.6 | GO:0070699 | type II activin receptor binding(GO:0070699) |
0.1 | 0.8 | GO:0097642 | calcitonin family receptor activity(GO:0097642) |
0.1 | 0.4 | GO:0015272 | ATP-activated inward rectifier potassium channel activity(GO:0015272) |
0.1 | 0.3 | GO:0003829 | beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase activity(GO:0003829) |
0.1 | 0.4 | GO:0004925 | prolactin receptor activity(GO:0004925) |
0.1 | 0.3 | GO:0003827 | alpha-1,3-mannosylglycoprotein 2-beta-N-acetylglucosaminyltransferase activity(GO:0003827) |
0.1 | 0.3 | GO:0047710 | bis(5'-adenosyl)-triphosphatase activity(GO:0047710) |
0.1 | 0.3 | GO:0050501 | hyaluronan synthase activity(GO:0050501) |
0.1 | 0.2 | GO:0016262 | protein N-acetylglucosaminyltransferase activity(GO:0016262) |
0.1 | 0.8 | GO:0071253 | connexin binding(GO:0071253) |
0.1 | 0.2 | GO:0008147 | structural constituent of bone(GO:0008147) |
0.1 | 0.5 | GO:0003828 | alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity(GO:0003828) |
0.1 | 0.2 | GO:0008457 | beta-galactosyl-N-acetylglucosaminylgalactosylglucosyl-ceramide beta-1,3-acetylglucosaminyltransferase activity(GO:0008457) lactosylceramide 1,3-N-acetyl-beta-D-glucosaminyltransferase activity(GO:0047256) |
0.1 | 0.3 | GO:0015410 | manganese-transporting ATPase activity(GO:0015410) |
0.1 | 0.5 | GO:0045545 | syndecan binding(GO:0045545) |
0.1 | 0.8 | GO:0003993 | acid phosphatase activity(GO:0003993) |
0.1 | 0.2 | GO:0048030 | disaccharide binding(GO:0048030) |
0.1 | 0.4 | GO:0035615 | clathrin adaptor activity(GO:0035615) endocytic adaptor activity(GO:0098748) |
0.1 | 0.8 | GO:0050700 | CARD domain binding(GO:0050700) |
0.1 | 0.4 | GO:0046848 | hydroxyapatite binding(GO:0046848) |
0.1 | 0.7 | GO:0016312 | inositol bisphosphate phosphatase activity(GO:0016312) |
0.1 | 0.3 | GO:0016833 | oxo-acid-lyase activity(GO:0016833) |
0.1 | 0.3 | GO:0016823 | hydrolase activity, acting on acid carbon-carbon bonds(GO:0016822) hydrolase activity, acting on acid carbon-carbon bonds, in ketonic substances(GO:0016823) |
0.1 | 0.4 | GO:0004704 | NF-kappaB-inducing kinase activity(GO:0004704) |
0.1 | 1.5 | GO:0051400 | BH domain binding(GO:0051400) |
0.1 | 0.2 | GO:0031896 | V2 vasopressin receptor binding(GO:0031896) |
0.1 | 0.8 | GO:0051870 | methotrexate binding(GO:0051870) |
0.1 | 0.5 | GO:0044729 | hemi-methylated DNA-binding(GO:0044729) |
0.1 | 0.2 | GO:0010698 | acetyltransferase activator activity(GO:0010698) |
0.1 | 0.1 | GO:0004800 | thyroxine 5'-deiodinase activity(GO:0004800) |
0.1 | 0.2 | GO:0030617 | transforming growth factor beta receptor, inhibitory cytoplasmic mediator activity(GO:0030617) |
0.1 | 1.1 | GO:0070008 | serine-type exopeptidase activity(GO:0070008) |
0.1 | 0.4 | GO:0008422 | beta-glucosidase activity(GO:0008422) |
0.1 | 0.8 | GO:0031994 | insulin-like growth factor I binding(GO:0031994) |
0.1 | 0.3 | GO:0015100 | cadmium ion transmembrane transporter activity(GO:0015086) lead ion transmembrane transporter activity(GO:0015094) vanadium ion transmembrane transporter activity(GO:0015100) ferrous iron uptake transmembrane transporter activity(GO:0015639) |
0.1 | 1.1 | GO:0001618 | virus receptor activity(GO:0001618) |
0.1 | 0.3 | GO:0004464 | leukotriene-C4 synthase activity(GO:0004464) |
0.1 | 0.5 | GO:0008020 | G-protein coupled photoreceptor activity(GO:0008020) |
0.1 | 0.2 | GO:0070891 | lipoteichoic acid binding(GO:0070891) |
0.1 | 1.1 | GO:0023026 | MHC class II protein complex binding(GO:0023026) |
0.1 | 0.2 | GO:0004379 | glycylpeptide N-tetradecanoyltransferase activity(GO:0004379) myristoyltransferase activity(GO:0019107) |
0.1 | 0.5 | GO:0001594 | trace-amine receptor activity(GO:0001594) |
0.1 | 0.8 | GO:0015194 | L-serine transmembrane transporter activity(GO:0015194) serine transmembrane transporter activity(GO:0022889) |
0.1 | 0.2 | GO:0019912 | cyclin-dependent protein kinase activating kinase activity(GO:0019912) |
0.1 | 0.2 | GO:0004962 | endothelin receptor activity(GO:0004962) |
0.1 | 0.4 | GO:0005047 | signal recognition particle binding(GO:0005047) |
0.1 | 0.4 | GO:0099609 | microtubule lateral binding(GO:0099609) |
0.1 | 0.3 | GO:0008142 | oxysterol binding(GO:0008142) |
0.1 | 0.2 | GO:0030942 | endoplasmic reticulum signal peptide binding(GO:0030942) |
0.1 | 0.2 | GO:0048763 | calcium-induced calcium release activity(GO:0048763) |
0.1 | 0.2 | GO:2001069 | glycogen binding(GO:2001069) |
0.1 | 0.3 | GO:0005138 | interleukin-6 receptor binding(GO:0005138) |
0.1 | 2.3 | GO:0005164 | tumor necrosis factor receptor binding(GO:0005164) |
0.1 | 0.2 | GO:0042936 | dipeptide transporter activity(GO:0042936) |
0.1 | 0.3 | GO:0008449 | N-acetylglucosamine-6-sulfatase activity(GO:0008449) |
0.1 | 1.5 | GO:0031489 | myosin V binding(GO:0031489) |
0.1 | 0.3 | GO:0004165 | dodecenoyl-CoA delta-isomerase activity(GO:0004165) |
0.1 | 0.2 | GO:0047192 | 1-alkylglycerophosphocholine O-acetyltransferase activity(GO:0047192) |
0.1 | 0.2 | GO:0071820 | N-box binding(GO:0071820) |
0.1 | 0.4 | GO:0004689 | phosphorylase kinase activity(GO:0004689) |
0.1 | 0.7 | GO:0005243 | gap junction channel activity(GO:0005243) |
0.1 | 0.3 | GO:1904288 | BAT3 complex binding(GO:1904288) |
0.1 | 0.2 | GO:0050436 | microfibril binding(GO:0050436) |
0.1 | 0.2 | GO:0008475 | procollagen-lysine 5-dioxygenase activity(GO:0008475) |
0.1 | 0.4 | GO:0004767 | sphingomyelin phosphodiesterase activity(GO:0004767) |
0.0 | 0.2 | GO:0033883 | pyridoxal phosphatase activity(GO:0033883) |
0.0 | 0.2 | GO:0060072 | large conductance calcium-activated potassium channel activity(GO:0060072) |
0.0 | 0.2 | GO:0016286 | small conductance calcium-activated potassium channel activity(GO:0016286) |
0.0 | 0.2 | GO:0070991 | medium-chain-acyl-CoA dehydrogenase activity(GO:0070991) |
0.0 | 1.1 | GO:0005184 | neuropeptide hormone activity(GO:0005184) |
0.0 | 0.3 | GO:0005324 | long-chain fatty acid transporter activity(GO:0005324) |
0.0 | 0.4 | GO:0097322 | 7SK snRNA binding(GO:0097322) |
0.0 | 0.1 | GO:0008109 | N-acetyllactosaminide beta-1,6-N-acetylglucosaminyltransferase activity(GO:0008109) |
0.0 | 0.2 | GO:0005384 | manganese ion transmembrane transporter activity(GO:0005384) |
0.0 | 0.6 | GO:0042043 | neurexin family protein binding(GO:0042043) |
0.0 | 0.8 | GO:0042923 | neuropeptide binding(GO:0042923) |
0.0 | 0.4 | GO:0008420 | CTD phosphatase activity(GO:0008420) |
0.0 | 0.2 | GO:0008184 | glycogen phosphorylase activity(GO:0008184) |
0.0 | 2.4 | GO:0005044 | scavenger receptor activity(GO:0005044) |
0.0 | 0.2 | GO:0016941 | natriuretic peptide receptor activity(GO:0016941) |
0.0 | 0.2 | GO:0031720 | haptoglobin binding(GO:0031720) |
0.0 | 0.2 | GO:0043237 | laminin-1 binding(GO:0043237) |
0.0 | 0.5 | GO:0008430 | selenium binding(GO:0008430) |
0.0 | 0.5 | GO:0019855 | calcium channel inhibitor activity(GO:0019855) |
0.0 | 0.3 | GO:0022833 | mechanically-gated ion channel activity(GO:0008381) mechanically gated channel activity(GO:0022833) |
0.0 | 0.1 | GO:0016901 | glycerol-3-phosphate dehydrogenase activity(GO:0004368) oxidoreductase activity, acting on the CH-OH group of donors, quinone or similar compound as acceptor(GO:0016901) |
0.0 | 0.0 | GO:0004566 | beta-glucuronidase activity(GO:0004566) |
0.0 | 0.1 | GO:0046624 | sphingolipid transporter activity(GO:0046624) |
0.0 | 0.6 | GO:0035612 | AP-2 adaptor complex binding(GO:0035612) |
0.0 | 0.5 | GO:0070569 | uridylyltransferase activity(GO:0070569) |
0.0 | 0.1 | GO:0045159 | myosin II binding(GO:0045159) |
0.0 | 0.3 | GO:0035586 | purinergic receptor activity(GO:0035586) |
0.0 | 0.8 | GO:0005161 | platelet-derived growth factor receptor binding(GO:0005161) |
0.0 | 0.6 | GO:0035497 | cAMP response element binding(GO:0035497) |
0.0 | 0.1 | GO:0004698 | calcium-dependent protein kinase C activity(GO:0004698) |
0.0 | 0.1 | GO:0035325 | Toll-like receptor binding(GO:0035325) |
0.0 | 0.1 | GO:0001225 | RNA polymerase II transcription coactivator binding(GO:0001225) |
0.0 | 0.5 | GO:1990459 | transferrin receptor binding(GO:1990459) |
0.0 | 0.2 | GO:0071558 | histone demethylase activity (H3-K27 specific)(GO:0071558) |
0.0 | 0.3 | GO:1990599 | 3' overhang single-stranded DNA endodeoxyribonuclease activity(GO:1990599) |
0.0 | 0.2 | GO:0004957 | prostaglandin E receptor activity(GO:0004957) |
0.0 | 0.1 | GO:0034617 | tetrahydrobiopterin binding(GO:0034617) |
0.0 | 0.2 | GO:0070740 | tubulin-glutamic acid ligase activity(GO:0070740) |
0.0 | 0.4 | GO:0005041 | low-density lipoprotein receptor activity(GO:0005041) |
0.0 | 0.2 | GO:0005250 | A-type (transient outward) potassium channel activity(GO:0005250) |
0.0 | 0.1 | GO:0019002 | GMP binding(GO:0019002) |
0.0 | 0.2 | GO:0019966 | interleukin-1 binding(GO:0019966) |
0.0 | 0.3 | GO:0055131 | C3HC4-type RING finger domain binding(GO:0055131) |
0.0 | 0.8 | GO:0001968 | fibronectin binding(GO:0001968) |
0.0 | 0.3 | GO:0038187 | signaling pattern recognition receptor activity(GO:0008329) pattern recognition receptor activity(GO:0038187) |
0.0 | 1.5 | GO:0005154 | epidermal growth factor receptor binding(GO:0005154) |
0.0 | 1.2 | GO:0042287 | MHC protein binding(GO:0042287) |
0.0 | 0.3 | GO:0005391 | sodium:potassium-exchanging ATPase activity(GO:0005391) |
0.0 | 0.4 | GO:0016493 | C-C chemokine receptor activity(GO:0016493) |
0.0 | 1.2 | GO:0005086 | ARF guanyl-nucleotide exchange factor activity(GO:0005086) |
0.0 | 1.5 | GO:0005484 | SNAP receptor activity(GO:0005484) |
0.0 | 0.1 | GO:0070513 | death domain binding(GO:0070513) |
0.0 | 0.2 | GO:0016721 | superoxide dismutase activity(GO:0004784) oxidoreductase activity, acting on superoxide radicals as acceptor(GO:0016721) |
0.0 | 0.1 | GO:0031752 | D5 dopamine receptor binding(GO:0031752) |
0.0 | 1.8 | GO:0070888 | E-box binding(GO:0070888) |
0.0 | 0.2 | GO:0010853 | cyclase activator activity(GO:0010853) guanylate cyclase activator activity(GO:0030250) |
0.0 | 1.0 | GO:0005035 | tumor necrosis factor-activated receptor activity(GO:0005031) death receptor activity(GO:0005035) |
0.0 | 0.3 | GO:0015379 | potassium:chloride symporter activity(GO:0015379) potassium ion symporter activity(GO:0022820) |
0.0 | 0.5 | GO:0005149 | interleukin-1 receptor binding(GO:0005149) |
0.0 | 0.1 | GO:0035529 | NADH pyrophosphatase activity(GO:0035529) |
0.0 | 0.1 | GO:0004814 | arginine-tRNA ligase activity(GO:0004814) |
0.0 | 0.9 | GO:0004198 | calcium-dependent cysteine-type endopeptidase activity(GO:0004198) |
0.0 | 0.2 | GO:0008035 | high-density lipoprotein particle binding(GO:0008035) |
0.0 | 1.1 | GO:0008187 | poly-pyrimidine tract binding(GO:0008187) |
0.0 | 0.1 | GO:0019776 | Atg8 ligase activity(GO:0019776) |
0.0 | 0.2 | GO:0004972 | NMDA glutamate receptor activity(GO:0004972) |
0.0 | 0.5 | GO:0045125 | bioactive lipid receptor activity(GO:0045125) |
0.0 | 1.0 | GO:0047617 | acyl-CoA hydrolase activity(GO:0047617) |
0.0 | 0.2 | GO:0003835 | beta-galactoside alpha-2,6-sialyltransferase activity(GO:0003835) |
0.0 | 0.5 | GO:0004559 | alpha-mannosidase activity(GO:0004559) |
0.0 | 0.5 | GO:0045295 | gamma-catenin binding(GO:0045295) |
0.0 | 0.9 | GO:0008395 | steroid hydroxylase activity(GO:0008395) |
0.0 | 0.1 | GO:0070051 | fibrinogen binding(GO:0070051) |
0.0 | 0.4 | GO:0097109 | neuroligin family protein binding(GO:0097109) |
0.0 | 0.3 | GO:0043024 | ribosomal small subunit binding(GO:0043024) |
0.0 | 0.2 | GO:0042030 | ATPase inhibitor activity(GO:0042030) |
0.0 | 0.5 | GO:0042608 | T cell receptor binding(GO:0042608) |
0.0 | 0.4 | GO:0052813 | phosphatidylinositol-4,5-bisphosphate 3-kinase activity(GO:0046934) phosphatidylinositol bisphosphate kinase activity(GO:0052813) |
0.0 | 1.4 | GO:0043027 | cysteine-type endopeptidase inhibitor activity involved in apoptotic process(GO:0043027) |
0.0 | 0.5 | GO:0045294 | alpha-catenin binding(GO:0045294) |
0.0 | 0.3 | GO:0004332 | fructose-bisphosphate aldolase activity(GO:0004332) |
0.0 | 1.0 | GO:0004012 | phospholipid-translocating ATPase activity(GO:0004012) |
0.0 | 0.2 | GO:0035374 | chondroitin sulfate binding(GO:0035374) |
0.0 | 1.1 | GO:0043539 | protein serine/threonine kinase activator activity(GO:0043539) |
0.0 | 0.6 | GO:0005229 | intracellular calcium activated chloride channel activity(GO:0005229) |
0.0 | 1.5 | GO:0004715 | non-membrane spanning protein tyrosine kinase activity(GO:0004715) |
0.0 | 0.2 | GO:0035614 | snRNA stem-loop binding(GO:0035614) |
0.0 | 0.4 | GO:0044548 | S100 protein binding(GO:0044548) |
0.0 | 0.2 | GO:0016308 | 1-phosphatidylinositol-4-phosphate 5-kinase activity(GO:0016308) |
0.0 | 1.2 | GO:0035255 | ionotropic glutamate receptor binding(GO:0035255) |
0.0 | 1.6 | GO:0045309 | protein phosphorylated amino acid binding(GO:0045309) |
0.0 | 0.7 | GO:0031683 | G-protein beta/gamma-subunit complex binding(GO:0031683) |
0.0 | 0.1 | GO:0047493 | sphingomyelin synthase activity(GO:0033188) ceramide cholinephosphotransferase activity(GO:0047493) |
0.0 | 0.2 | GO:0061578 | Lys63-specific deubiquitinase activity(GO:0061578) |
0.0 | 0.3 | GO:0032050 | clathrin heavy chain binding(GO:0032050) |
0.0 | 0.7 | GO:0005158 | insulin receptor binding(GO:0005158) |
0.0 | 0.6 | GO:0000030 | mannosyltransferase activity(GO:0000030) |
0.0 | 0.1 | GO:0003880 | protein C-terminal carboxyl O-methyltransferase activity(GO:0003880) |
0.0 | 0.3 | GO:0045499 | chemorepellent activity(GO:0045499) |
0.0 | 0.1 | GO:0005171 | hepatocyte growth factor receptor binding(GO:0005171) |
0.0 | 0.1 | GO:0031014 | troponin T binding(GO:0031014) |
0.0 | 0.2 | GO:0005021 | vascular endothelial growth factor-activated receptor activity(GO:0005021) |
0.0 | 0.5 | GO:0005537 | mannose binding(GO:0005537) |
0.0 | 0.7 | GO:0005521 | lamin binding(GO:0005521) |
0.0 | 0.2 | GO:1990715 | mRNA CDS binding(GO:1990715) |
0.0 | 0.8 | GO:0043325 | phosphatidylinositol-3,4-bisphosphate binding(GO:0043325) |
0.0 | 0.2 | GO:0036312 | phosphatidylinositol 3-kinase regulatory subunit binding(GO:0036312) |
0.0 | 0.2 | GO:0008140 | cAMP response element binding protein binding(GO:0008140) |
0.0 | 0.2 | GO:0003910 | DNA ligase activity(GO:0003909) DNA ligase (ATP) activity(GO:0003910) |
0.0 | 0.1 | GO:0004949 | cannabinoid receptor activity(GO:0004949) |
0.0 | 0.1 | GO:0034714 | type III transforming growth factor beta receptor binding(GO:0034714) |
0.0 | 0.2 | GO:0042500 | aspartic endopeptidase activity, intramembrane cleaving(GO:0042500) |
0.0 | 0.8 | GO:0015020 | glucuronosyltransferase activity(GO:0015020) |
0.0 | 0.2 | GO:0010861 | thyroid hormone receptor activator activity(GO:0010861) |
0.0 | 0.3 | GO:0004439 | phosphatidylinositol-4,5-bisphosphate 5-phosphatase activity(GO:0004439) |
0.0 | 0.3 | GO:0005522 | profilin binding(GO:0005522) |
0.0 | 0.1 | GO:0016015 | morphogen activity(GO:0016015) |
0.0 | 1.3 | GO:0019209 | kinase activator activity(GO:0019209) |
0.0 | 0.1 | GO:0045131 | pre-mRNA branch point binding(GO:0045131) |
0.0 | 3.6 | GO:0004252 | serine-type endopeptidase activity(GO:0004252) |
0.0 | 0.2 | GO:0017034 | Rap guanyl-nucleotide exchange factor activity(GO:0017034) |
0.0 | 0.4 | GO:0030159 | receptor signaling complex scaffold activity(GO:0030159) |
0.0 | 0.1 | GO:0031543 | peptidyl-proline dioxygenase activity(GO:0031543) |
0.0 | 0.1 | GO:0005220 | inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0005220) |
0.0 | 0.5 | GO:0004653 | polypeptide N-acetylgalactosaminyltransferase activity(GO:0004653) |
0.0 | 0.2 | GO:0008484 | sulfuric ester hydrolase activity(GO:0008484) |
0.0 | 0.2 | GO:0050694 | galactose 3-O-sulfotransferase activity(GO:0050694) |
0.0 | 0.6 | GO:0004709 | MAP kinase kinase kinase activity(GO:0004709) |
0.0 | 0.3 | GO:0019841 | retinol binding(GO:0019841) |
0.0 | 1.0 | GO:0050699 | WW domain binding(GO:0050699) |
0.0 | 4.0 | GO:0030246 | carbohydrate binding(GO:0030246) |
0.0 | 0.3 | GO:0019911 | structural constituent of myelin sheath(GO:0019911) |
0.0 | 0.1 | GO:0016972 | thiol oxidase activity(GO:0016972) |
0.0 | 0.4 | GO:0045504 | dynein heavy chain binding(GO:0045504) |
0.0 | 0.2 | GO:0047499 | calcium-independent phospholipase A2 activity(GO:0047499) |
0.0 | 0.1 | GO:0004515 | nicotinamide-nucleotide adenylyltransferase activity(GO:0000309) nicotinate-nucleotide adenylyltransferase activity(GO:0004515) |
0.0 | 0.2 | GO:1901702 | urate transmembrane transporter activity(GO:0015143) salt transmembrane transporter activity(GO:1901702) |
0.0 | 0.1 | GO:0001888 | glucuronyl-galactosyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity(GO:0001888) |
0.0 | 0.5 | GO:0070273 | phosphatidylinositol-4-phosphate binding(GO:0070273) |
0.0 | 0.0 | GO:0008517 | folic acid transporter activity(GO:0008517) |
0.0 | 0.2 | GO:0035004 | 1-phosphatidylinositol-3-kinase activity(GO:0016303) phosphatidylinositol 3-kinase activity(GO:0035004) |
0.0 | 0.1 | GO:0046403 | polynucleotide 3'-phosphatase activity(GO:0046403) |
0.0 | 0.4 | GO:0016702 | oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen(GO:0016702) |
0.0 | 0.3 | GO:0004993 | G-protein coupled serotonin receptor activity(GO:0004993) |
0.0 | 0.1 | GO:0051021 | GDP-dissociation inhibitor binding(GO:0051021) |
0.0 | 0.1 | GO:0005000 | vasopressin receptor activity(GO:0005000) |
0.0 | 0.1 | GO:0016530 | metallochaperone activity(GO:0016530) copper chaperone activity(GO:0016531) cuprous ion binding(GO:1903136) |
0.0 | 1.3 | GO:0048306 | calcium-dependent protein binding(GO:0048306) |
0.0 | 0.1 | GO:0035251 | UDP-glucosyltransferase activity(GO:0035251) |
0.0 | 0.1 | GO:0036313 | phosphatidylinositol 3-kinase catalytic subunit binding(GO:0036313) |
0.0 | 0.1 | GO:0004565 | beta-galactosidase activity(GO:0004565) |
0.0 | 0.1 | GO:0071987 | WD40-repeat domain binding(GO:0071987) |
0.0 | 0.3 | GO:0015279 | store-operated calcium channel activity(GO:0015279) |
0.0 | 0.1 | GO:0004967 | glucagon receptor activity(GO:0004967) |
0.0 | 0.6 | GO:0050840 | extracellular matrix binding(GO:0050840) |
0.0 | 0.2 | GO:0003876 | AMP deaminase activity(GO:0003876) adenosine-phosphate deaminase activity(GO:0047623) |
0.0 | 0.4 | GO:0004697 | protein kinase C activity(GO:0004697) |
0.0 | 0.3 | GO:0005542 | folic acid binding(GO:0005542) |
0.0 | 0.1 | GO:0010858 | calcium-dependent protein kinase inhibitor activity(GO:0008427) calcium-dependent protein kinase regulator activity(GO:0010858) |
0.0 | 0.0 | GO:0030229 | very-low-density lipoprotein particle receptor activity(GO:0030229) |
0.0 | 0.9 | GO:0017112 | Rab guanyl-nucleotide exchange factor activity(GO:0017112) |
0.0 | 0.1 | GO:0018479 | benzaldehyde dehydrogenase (NAD+) activity(GO:0018479) |
0.0 | 0.1 | GO:0051377 | mannose-ethanolamine phosphotransferase activity(GO:0051377) |
0.0 | 0.3 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
0.0 | 0.1 | GO:0016401 | palmitoyl-CoA oxidase activity(GO:0016401) |
0.0 | 0.2 | GO:0015250 | water channel activity(GO:0015250) |
0.0 | 0.1 | GO:0052629 | phosphatidylinositol-3,5-bisphosphate 3-phosphatase activity(GO:0052629) |
0.0 | 0.2 | GO:0032813 | tumor necrosis factor receptor superfamily binding(GO:0032813) |
0.0 | 0.0 | GO:0030977 | taurine binding(GO:0030977) |
0.0 | 0.3 | GO:0030742 | GTP-dependent protein binding(GO:0030742) |
0.0 | 0.3 | GO:0004190 | aspartic-type endopeptidase activity(GO:0004190) aspartic-type peptidase activity(GO:0070001) |
0.0 | 0.0 | GO:0002153 | steroid receptor RNA activator RNA binding(GO:0002153) |
0.0 | 0.2 | GO:0008417 | fucosyltransferase activity(GO:0008417) |
0.0 | 0.3 | GO:0008510 | sodium:bicarbonate symporter activity(GO:0008510) |
0.0 | 0.1 | GO:0004013 | adenosylhomocysteinase activity(GO:0004013) trialkylsulfonium hydrolase activity(GO:0016802) |
0.0 | 0.1 | GO:0044388 | small protein activating enzyme binding(GO:0044388) |
0.0 | 0.1 | GO:0008603 | cAMP-dependent protein kinase regulator activity(GO:0008603) |
0.0 | 0.3 | GO:0070006 | metalloaminopeptidase activity(GO:0070006) |
0.0 | 0.3 | GO:0005528 | macrolide binding(GO:0005527) FK506 binding(GO:0005528) |
0.0 | 0.1 | GO:0004103 | choline kinase activity(GO:0004103) |
0.0 | 0.1 | GO:0001640 | adenylate cyclase inhibiting G-protein coupled glutamate receptor activity(GO:0001640) |
0.0 | 0.1 | GO:0005459 | UDP-galactose transmembrane transporter activity(GO:0005459) |
0.0 | 0.1 | GO:0001069 | regulatory region RNA binding(GO:0001069) |
0.0 | 0.2 | GO:0016755 | transferase activity, transferring amino-acyl groups(GO:0016755) |
0.0 | 0.2 | GO:0003746 | translation elongation factor activity(GO:0003746) |
0.0 | 0.3 | GO:0015238 | drug transmembrane transporter activity(GO:0015238) |
0.0 | 0.5 | GO:0045505 | dynein intermediate chain binding(GO:0045505) |
0.0 | 0.5 | GO:0005544 | calcium-dependent phospholipid binding(GO:0005544) |
0.0 | 0.1 | GO:0003953 | NAD+ nucleosidase activity(GO:0003953) |
0.0 | 0.0 | GO:0030549 | acetylcholine receptor activator activity(GO:0030549) |
0.0 | 0.1 | GO:0016505 | peptidase activator activity involved in apoptotic process(GO:0016505) |
0.0 | 0.3 | GO:0008198 | ferrous iron binding(GO:0008198) |
0.0 | 4.3 | GO:0005525 | GTP binding(GO:0005525) |
0.0 | 0.1 | GO:0046790 | virion binding(GO:0046790) |
0.0 | 0.1 | GO:0008889 | glycerophosphodiester phosphodiesterase activity(GO:0008889) |
0.0 | 0.0 | GO:0036033 | mediator complex binding(GO:0036033) |
0.0 | 0.1 | GO:0008131 | primary amine oxidase activity(GO:0008131) |
0.0 | 0.1 | GO:0008239 | dipeptidyl-peptidase activity(GO:0008239) |
0.0 | 0.1 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
0.0 | 0.0 | GO:0015377 | cation:chloride symporter activity(GO:0015377) |
0.0 | 0.2 | GO:0047372 | acylglycerol lipase activity(GO:0047372) |
0.0 | 0.1 | GO:0003945 | N-acetyllactosamine synthase activity(GO:0003945) |
0.0 | 0.1 | GO:0042301 | phosphate ion binding(GO:0042301) |
0.0 | 0.1 | GO:0016907 | G-protein coupled acetylcholine receptor activity(GO:0016907) |
0.0 | 0.1 | GO:0005520 | insulin-like growth factor binding(GO:0005520) |
0.0 | 0.0 | GO:0008176 | tRNA (guanine-N7-)-methyltransferase activity(GO:0008176) |
0.0 | 0.2 | GO:0070403 | NAD+ binding(GO:0070403) |
0.0 | 0.4 | GO:0008378 | galactosyltransferase activity(GO:0008378) |
0.0 | 0.0 | GO:0004060 | arylamine N-acetyltransferase activity(GO:0004060) |
0.0 | 0.2 | GO:0008641 | small protein activating enzyme activity(GO:0008641) |
0.0 | 0.0 | GO:0032139 | dinucleotide insertion or deletion binding(GO:0032139) single guanine insertion binding(GO:0032142) |
0.0 | 0.3 | GO:0005112 | Notch binding(GO:0005112) |
0.0 | 0.2 | GO:0008106 | alcohol dehydrogenase (NADP+) activity(GO:0008106) |
0.0 | 0.1 | GO:0004886 | 9-cis retinoic acid receptor activity(GO:0004886) |
0.0 | 0.1 | GO:0043522 | leucine zipper domain binding(GO:0043522) |
0.0 | 0.3 | GO:1900750 | glutathione binding(GO:0043295) oligopeptide binding(GO:1900750) |
0.0 | 0.7 | GO:0020037 | heme binding(GO:0020037) |
0.0 | 0.1 | GO:1990825 | sequence-specific mRNA binding(GO:1990825) |
0.0 | 0.0 | GO:0016647 | oxidoreductase activity, acting on the CH-NH group of donors, oxygen as acceptor(GO:0016647) |
0.0 | 0.2 | GO:1990381 | ubiquitin-specific protease binding(GO:1990381) |
0.0 | 0.1 | GO:0015501 | glutamate:sodium symporter activity(GO:0015501) |
0.0 | 0.1 | GO:0035033 | histone deacetylase regulator activity(GO:0035033) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.2 | 8.4 | PID TOLL ENDOGENOUS PATHWAY | Endogenous TLR signaling |
0.2 | 0.5 | PID TCR RAS PATHWAY | Ras signaling in the CD4+ TCR pathway |
0.2 | 2.9 | SA MMP CYTOKINE CONNECTION | Cytokines can induce activation of matrix metalloproteinases, which degrade extracellular matrix. |
0.1 | 2.4 | PID CONE PATHWAY | Visual signal transduction: Cones |
0.1 | 0.2 | SA G1 AND S PHASES | Cdk2, 4, and 6 bind cyclin D in G1, while cdk2/cyclin E promotes the G1/S transition. |
0.1 | 5.8 | PID CD8 TCR PATHWAY | TCR signaling in naïve CD8+ T cells |
0.1 | 1.9 | ST G ALPHA S PATHWAY | G alpha s Pathway |
0.1 | 2.6 | PID CD40 PATHWAY | CD40/CD40L signaling |
0.1 | 3.0 | PID AMB2 NEUTROPHILS PATHWAY | amb2 Integrin signaling |
0.1 | 1.9 | PID INTEGRIN CS PATHWAY | Integrin family cell surface interactions |
0.1 | 2.0 | PID INTEGRIN A9B1 PATHWAY | Alpha9 beta1 integrin signaling events |
0.1 | 2.3 | PID IL3 PATHWAY | IL3-mediated signaling events |
0.1 | 2.0 | PID P38 MK2 PATHWAY | p38 signaling mediated by MAPKAP kinases |
0.1 | 0.5 | PID GMCSF PATHWAY | GMCSF-mediated signaling events |
0.1 | 2.2 | PID IL8 CXCR2 PATHWAY | IL8- and CXCR2-mediated signaling events |
0.1 | 1.8 | PID NCADHERIN PATHWAY | N-cadherin signaling events |
0.1 | 0.5 | PID RHODOPSIN PATHWAY | Visual signal transduction: Rods |
0.0 | 2.0 | PID A6B1 A6B4 INTEGRIN PATHWAY | a6b1 and a6b4 Integrin signaling |
0.0 | 1.1 | PID SYNDECAN 4 PATHWAY | Syndecan-4-mediated signaling events |
0.0 | 1.9 | PID BCR 5PATHWAY | BCR signaling pathway |
0.0 | 0.9 | PID TCR PATHWAY | TCR signaling in naïve CD4+ T cells |
0.0 | 1.7 | PID ENDOTHELIN PATHWAY | Endothelins |
0.0 | 2.7 | PID NFAT TFPATHWAY | Calcineurin-regulated NFAT-dependent transcription in lymphocytes |
0.0 | 1.2 | PID HDAC CLASSIII PATHWAY | Signaling events mediated by HDAC Class III |
0.0 | 1.5 | PID IL4 2PATHWAY | IL4-mediated signaling events |
0.0 | 0.0 | PID NFKAPPAB ATYPICAL PATHWAY | Atypical NF-kappaB pathway |
0.0 | 0.9 | PID IL6 7 PATHWAY | IL6-mediated signaling events |
0.0 | 0.2 | ST TYPE I INTERFERON PATHWAY | Type I Interferon (alpha/beta IFN) Pathway |
0.0 | 0.5 | PID S1P S1P2 PATHWAY | S1P2 pathway |
0.0 | 0.1 | PID HIV NEF PATHWAY | HIV-1 Nef: Negative effector of Fas and TNF-alpha |
0.0 | 7.1 | NABA ECM GLYCOPROTEINS | Genes encoding structural ECM glycoproteins |
0.0 | 1.4 | NABA PROTEOGLYCANS | Genes encoding proteoglycans |
0.0 | 1.7 | PID CASPASE PATHWAY | Caspase cascade in apoptosis |
0.0 | 1.1 | SIG BCR SIGNALING PATHWAY | Members of the BCR signaling pathway |
0.0 | 1.9 | PID P75 NTR PATHWAY | p75(NTR)-mediated signaling |
0.0 | 0.2 | PID VEGF VEGFR PATHWAY | VEGF and VEGFR signaling network |
0.0 | 1.9 | PID HES HEY PATHWAY | Notch-mediated HES/HEY network |
0.0 | 0.2 | PID ARF6 DOWNSTREAM PATHWAY | Arf6 downstream pathway |
0.0 | 1.2 | PID BMP PATHWAY | BMP receptor signaling |
0.0 | 0.2 | PID IL8 CXCR1 PATHWAY | IL8- and CXCR1-mediated signaling events |
0.0 | 0.2 | PID SYNDECAN 3 PATHWAY | Syndecan-3-mediated signaling events |
0.0 | 0.7 | PID CXCR4 PATHWAY | CXCR4-mediated signaling events |
0.0 | 4.9 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
0.0 | 0.1 | PID IL2 STAT5 PATHWAY | IL2 signaling events mediated by STAT5 |
0.0 | 0.1 | PID ERBB1 RECEPTOR PROXIMAL PATHWAY | EGF receptor (ErbB1) signaling pathway |
0.0 | 7.5 | NABA SECRETED FACTORS | Genes encoding secreted soluble factors |
0.0 | 0.6 | PID DNA PK PATHWAY | DNA-PK pathway in nonhomologous end joining |
0.0 | 0.4 | PID AJDISS 2PATHWAY | Posttranslational regulation of adherens junction stability and dissassembly |
0.0 | 1.4 | PID AR TF PATHWAY | Regulation of Androgen receptor activity |
0.0 | 0.4 | PID RET PATHWAY | Signaling events regulated by Ret tyrosine kinase |
0.0 | 0.7 | PID ERBB1 INTERNALIZATION PATHWAY | Internalization of ErbB1 |
0.0 | 0.0 | ST PAC1 RECEPTOR PATHWAY | PAC1 Receptor Pathway |
0.0 | 0.5 | PID PS1 PATHWAY | Presenilin action in Notch and Wnt signaling |
0.0 | 0.4 | PID PTP1B PATHWAY | Signaling events mediated by PTP1B |
0.0 | 0.3 | PID KIT PATHWAY | Signaling events mediated by Stem cell factor receptor (c-Kit) |
0.0 | 0.2 | PID FRA PATHWAY | Validated transcriptional targets of AP1 family members Fra1 and Fra2 |
0.0 | 0.1 | PID MAPK TRK PATHWAY | Trk receptor signaling mediated by the MAPK pathway |
0.0 | 0.2 | PID INSULIN GLUCOSE PATHWAY | Insulin-mediated glucose transport |
0.0 | 1.5 | PID P53 DOWNSTREAM PATHWAY | Direct p53 effectors |
0.0 | 0.1 | PID INTEGRIN A4B1 PATHWAY | Alpha4 beta1 integrin signaling events |
0.0 | 0.8 | PID RAC1 REG PATHWAY | Regulation of RAC1 activity |
0.0 | 2.7 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
0.0 | 0.1 | PID NFKAPPAB CANONICAL PATHWAY | Canonical NF-kappaB pathway |
0.0 | 0.1 | PID TRAIL PATHWAY | TRAIL signaling pathway |
0.0 | 0.3 | PID P38 MKK3 6PATHWAY | p38 MAPK signaling pathway |
0.0 | 0.1 | PID HDAC CLASSII PATHWAY | Signaling events mediated by HDAC Class II |
0.0 | 0.4 | PID ARF6 TRAFFICKING PATHWAY | Arf6 trafficking events |
0.0 | 0.2 | PID EPHB FWD PATHWAY | EPHB forward signaling |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.3 | 0.9 | REACTOME ENDOSOMAL VACUOLAR PATHWAY | Genes involved in Endosomal/Vacuolar pathway |
0.2 | 4.4 | REACTOME PECAM1 INTERACTIONS | Genes involved in PECAM1 interactions |
0.2 | 0.2 | REACTOME THROMBOXANE SIGNALLING THROUGH TP RECEPTOR | Genes involved in Thromboxane signalling through TP receptor |
0.2 | 2.0 | REACTOME IKK COMPLEX RECRUITMENT MEDIATED BY RIP1 | Genes involved in IKK complex recruitment mediated by RIP1 |
0.2 | 5.7 | REACTOME LATENT INFECTION OF HOMO SAPIENS WITH MYCOBACTERIUM TUBERCULOSIS | Genes involved in Latent infection of Homo sapiens with Mycobacterium tuberculosis |
0.1 | 2.1 | REACTOME COMMON PATHWAY | Genes involved in Common Pathway |
0.1 | 1.7 | REACTOME REGULATION OF COMPLEMENT CASCADE | Genes involved in Regulation of Complement cascade |
0.1 | 2.0 | REACTOME SIGNAL REGULATORY PROTEIN SIRP FAMILY INTERACTIONS | Genes involved in Signal regulatory protein (SIRP) family interactions |
0.1 | 2.7 | REACTOME NUCLEOTIDE LIKE PURINERGIC RECEPTORS | Genes involved in Nucleotide-like (purinergic) receptors |
0.1 | 1.2 | REACTOME GRB2 SOS PROVIDES LINKAGE TO MAPK SIGNALING FOR INTERGRINS | Genes involved in GRB2:SOS provides linkage to MAPK signaling for Intergrins |
0.1 | 5.6 | REACTOME CHEMOKINE RECEPTORS BIND CHEMOKINES | Genes involved in Chemokine receptors bind chemokines |
0.1 | 1.4 | REACTOME PHOSPHORYLATION OF CD3 AND TCR ZETA CHAINS | Genes involved in Phosphorylation of CD3 and TCR zeta chains |
0.1 | 2.4 | REACTOME ZINC TRANSPORTERS | Genes involved in Zinc transporters |
0.1 | 1.2 | REACTOME EXTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Extrinsic Pathway for Apoptosis |
0.1 | 1.2 | REACTOME THE NLRP3 INFLAMMASOME | Genes involved in The NLRP3 inflammasome |
0.1 | 0.4 | REACTOME DEFENSINS | Genes involved in Defensins |
0.1 | 1.2 | REACTOME N GLYCAN TRIMMING IN THE ER AND CALNEXIN CALRETICULIN CYCLE | Genes involved in N-glycan trimming in the ER and Calnexin/Calreticulin cycle |
0.1 | 0.7 | REACTOME ORGANIC CATION ANION ZWITTERION TRANSPORT | Genes involved in Organic cation/anion/zwitterion transport |
0.1 | 2.8 | REACTOME ANTIGEN ACTIVATES B CELL RECEPTOR LEADING TO GENERATION OF SECOND MESSENGERS | Genes involved in Antigen Activates B Cell Receptor Leading to Generation of Second Messengers |
0.1 | 1.3 | REACTOME GENERATION OF SECOND MESSENGER MOLECULES | Genes involved in Generation of second messenger molecules |
0.1 | 1.6 | REACTOME GABA SYNTHESIS RELEASE REUPTAKE AND DEGRADATION | Genes involved in GABA synthesis, release, reuptake and degradation |
0.1 | 1.4 | REACTOME CYTOCHROME P450 ARRANGED BY SUBSTRATE TYPE | Genes involved in Cytochrome P450 - arranged by substrate type |
0.1 | 1.1 | REACTOME GAP JUNCTION ASSEMBLY | Genes involved in Gap junction assembly |
0.1 | 1.9 | REACTOME KINESINS | Genes involved in Kinesins |
0.1 | 1.3 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
0.1 | 0.7 | REACTOME CYTOSOLIC SULFONATION OF SMALL MOLECULES | Genes involved in Cytosolic sulfonation of small molecules |
0.1 | 0.5 | REACTOME OPSINS | Genes involved in Opsins |
0.1 | 0.3 | REACTOME ELEVATION OF CYTOSOLIC CA2 LEVELS | Genes involved in Elevation of cytosolic Ca2+ levels |
0.1 | 0.3 | REACTOME G PROTEIN BETA GAMMA SIGNALLING | Genes involved in G-protein beta:gamma signalling |
0.1 | 2.0 | REACTOME NOD1 2 SIGNALING PATHWAY | Genes involved in NOD1/2 Signaling Pathway |
0.1 | 0.4 | REACTOME HYALURONAN UPTAKE AND DEGRADATION | Genes involved in Hyaluronan uptake and degradation |
0.1 | 0.4 | REACTOME TRAFFICKING AND PROCESSING OF ENDOSOMAL TLR | Genes involved in Trafficking and processing of endosomal TLR |
0.1 | 0.7 | REACTOME RIP MEDIATED NFKB ACTIVATION VIA DAI | Genes involved in RIP-mediated NFkB activation via DAI |
0.1 | 0.6 | REACTOME REGULATION OF INSULIN SECRETION BY ACETYLCHOLINE | Genes involved in Regulation of Insulin Secretion by Acetylcholine |
0.1 | 1.0 | REACTOME ACYL CHAIN REMODELLING OF PI | Genes involved in Acyl chain remodelling of PI |
0.1 | 2.4 | REACTOME IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL | Genes involved in Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell |
0.1 | 1.1 | REACTOME PROLACTIN RECEPTOR SIGNALING | Genes involved in Prolactin receptor signaling |
0.1 | 0.7 | REACTOME EICOSANOID LIGAND BINDING RECEPTORS | Genes involved in Eicosanoid ligand-binding receptors |
0.1 | 0.3 | REACTOME THE ROLE OF NEF IN HIV1 REPLICATION AND DISEASE PATHOGENESIS | Genes involved in The role of Nef in HIV-1 replication and disease pathogenesis |
0.1 | 0.4 | REACTOME CREATION OF C4 AND C2 ACTIVATORS | Genes involved in Creation of C4 and C2 activators |
0.1 | 0.7 | REACTOME APOPTOSIS INDUCED DNA FRAGMENTATION | Genes involved in Apoptosis induced DNA fragmentation |
0.1 | 0.5 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION IN TLR7 8 OR 9 SIGNALING | Genes involved in TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling |
0.0 | 0.3 | REACTOME PIP3 ACTIVATES AKT SIGNALING | Genes involved in PIP3 activates AKT signaling |
0.0 | 0.6 | REACTOME REGULATION OF IFNA SIGNALING | Genes involved in Regulation of IFNA signaling |
0.0 | 1.9 | REACTOME SEMA4D IN SEMAPHORIN SIGNALING | Genes involved in Sema4D in semaphorin signaling |
0.0 | 1.9 | REACTOME TIGHT JUNCTION INTERACTIONS | Genes involved in Tight junction interactions |
0.0 | 0.8 | REACTOME IL RECEPTOR SHC SIGNALING | Genes involved in Interleukin receptor SHC signaling |
0.0 | 1.4 | REACTOME BASIGIN INTERACTIONS | Genes involved in Basigin interactions |
0.0 | 1.7 | REACTOME CELL SURFACE INTERACTIONS AT THE VASCULAR WALL | Genes involved in Cell surface interactions at the vascular wall |
0.0 | 0.7 | REACTOME SYNTHESIS OF PIPS AT THE LATE ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the late endosome membrane |
0.0 | 0.4 | REACTOME KERATAN SULFATE DEGRADATION | Genes involved in Keratan sulfate degradation |
0.0 | 0.6 | REACTOME REGULATION OF INSULIN SECRETION BY GLUCAGON LIKE PEPTIDE1 | Genes involved in Regulation of Insulin Secretion by Glucagon-like Peptide-1 |
0.0 | 0.8 | REACTOME ENOS ACTIVATION AND REGULATION | Genes involved in eNOS activation and regulation |
0.0 | 0.7 | REACTOME PHASE1 FUNCTIONALIZATION OF COMPOUNDS | Genes involved in Phase 1 - Functionalization of compounds |
0.0 | 0.5 | REACTOME GLUTAMATE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Glutamate Neurotransmitter Release Cycle |
0.0 | 0.3 | REACTOME INFLAMMASOMES | Genes involved in Inflammasomes |
0.0 | 0.4 | REACTOME AKT PHOSPHORYLATES TARGETS IN THE CYTOSOL | Genes involved in AKT phosphorylates targets in the cytosol |
0.0 | 2.6 | REACTOME REGULATION OF WATER BALANCE BY RENAL AQUAPORINS | Genes involved in Regulation of Water Balance by Renal Aquaporins |
0.0 | 0.6 | REACTOME P75 NTR RECEPTOR MEDIATED SIGNALLING | Genes involved in p75 NTR receptor-mediated signalling |
0.0 | 0.3 | REACTOME DOWNSTREAM TCR SIGNALING | Genes involved in Downstream TCR signaling |
0.0 | 1.7 | REACTOME ACTIVATION OF CHAPERONE GENES BY XBP1S | Genes involved in Activation of Chaperone Genes by XBP1(S) |
0.0 | 0.6 | REACTOME DEGRADATION OF THE EXTRACELLULAR MATRIX | Genes involved in Degradation of the extracellular matrix |
0.0 | 0.3 | REACTOME COMPLEMENT CASCADE | Genes involved in Complement cascade |
0.0 | 1.5 | REACTOME REGULATION OF BETA CELL DEVELOPMENT | Genes involved in Regulation of beta-cell development |
0.0 | 0.5 | REACTOME GLYCOGEN BREAKDOWN GLYCOGENOLYSIS | Genes involved in Glycogen breakdown (glycogenolysis) |
0.0 | 0.2 | REACTOME THROMBIN SIGNALLING THROUGH PROTEINASE ACTIVATED RECEPTORS PARS | Genes involved in Thrombin signalling through proteinase activated receptors (PARs) |
0.0 | 0.7 | REACTOME HS GAG DEGRADATION | Genes involved in HS-GAG degradation |
0.0 | 0.2 | REACTOME SEMA3A PAK DEPENDENT AXON REPULSION | Genes involved in Sema3A PAK dependent Axon repulsion |
0.0 | 0.7 | REACTOME ACTIVATION OF BH3 ONLY PROTEINS | Genes involved in Activation of BH3-only proteins |
0.0 | 0.9 | REACTOME COSTIMULATION BY THE CD28 FAMILY | Genes involved in Costimulation by the CD28 family |
0.0 | 0.5 | REACTOME A TETRASACCHARIDE LINKER SEQUENCE IS REQUIRED FOR GAG SYNTHESIS | Genes involved in A tetrasaccharide linker sequence is required for GAG synthesis |
0.0 | 0.1 | REACTOME SIGNAL AMPLIFICATION | Genes involved in Signal amplification |
0.0 | 0.4 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GLP1 | Genes involved in Synthesis, Secretion, and Inactivation of Glucagon-like Peptide-1 (GLP-1) |
0.0 | 0.8 | REACTOME LIPOPROTEIN METABOLISM | Genes involved in Lipoprotein metabolism |
0.0 | 0.2 | REACTOME PLATELET ADHESION TO EXPOSED COLLAGEN | Genes involved in Platelet Adhesion to exposed collagen |
0.0 | 0.6 | REACTOME PRE NOTCH TRANSCRIPTION AND TRANSLATION | Genes involved in Pre-NOTCH Transcription and Translation |
0.0 | 0.2 | REACTOME P38MAPK EVENTS | Genes involved in p38MAPK events |
0.0 | 0.4 | REACTOME STEROID HORMONES | Genes involved in Steroid hormones |
0.0 | 0.3 | REACTOME SEROTONIN RECEPTORS | Genes involved in Serotonin receptors |
0.0 | 0.3 | REACTOME APOPTOTIC CLEAVAGE OF CELL ADHESION PROTEINS | Genes involved in Apoptotic cleavage of cell adhesion proteins |
0.0 | 0.4 | REACTOME PURINE SALVAGE | Genes involved in Purine salvage |
0.0 | 0.1 | REACTOME AUTODEGRADATION OF THE E3 UBIQUITIN LIGASE COP1 | Genes involved in Autodegradation of the E3 ubiquitin ligase COP1 |
0.0 | 0.1 | REACTOME SPRY REGULATION OF FGF SIGNALING | Genes involved in Spry regulation of FGF signaling |
0.0 | 0.2 | REACTOME EGFR DOWNREGULATION | Genes involved in EGFR downregulation |
0.0 | 0.2 | REACTOME CRMPS IN SEMA3A SIGNALING | Genes involved in CRMPs in Sema3A signaling |
0.0 | 2.8 | REACTOME CLASS A1 RHODOPSIN LIKE RECEPTORS | Genes involved in Class A/1 (Rhodopsin-like receptors) |
0.0 | 0.4 | REACTOME RAS ACTIVATION UOPN CA2 INFUX THROUGH NMDA RECEPTOR | Genes involved in Ras activation uopn Ca2+ infux through NMDA receptor |
0.0 | 0.9 | REACTOME NCAM1 INTERACTIONS | Genes involved in NCAM1 interactions |
0.0 | 0.3 | REACTOME FACILITATIVE NA INDEPENDENT GLUCOSE TRANSPORTERS | Genes involved in Facilitative Na+-independent glucose transporters |
0.0 | 0.4 | REACTOME PRE NOTCH PROCESSING IN GOLGI | Genes involved in Pre-NOTCH Processing in Golgi |
0.0 | 0.3 | REACTOME SYNTHESIS OF SUBSTRATES IN N GLYCAN BIOSYTHESIS | Genes involved in Synthesis of substrates in N-glycan biosythesis |
0.0 | 0.1 | REACTOME ADVANCED GLYCOSYLATION ENDPRODUCT RECEPTOR SIGNALING | Genes involved in Advanced glycosylation endproduct receptor signaling |
0.0 | 0.4 | REACTOME RETROGRADE NEUROTROPHIN SIGNALLING | Genes involved in Retrograde neurotrophin signalling |
0.0 | 0.2 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
0.0 | 0.3 | REACTOME NEPHRIN INTERACTIONS | Genes involved in Nephrin interactions |
0.0 | 0.0 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GIP | Genes involved in Synthesis, Secretion, and Inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP) |
0.0 | 0.4 | REACTOME ENDOSOMAL SORTING COMPLEX REQUIRED FOR TRANSPORT ESCRT | Genes involved in Endosomal Sorting Complex Required For Transport (ESCRT) |
0.0 | 0.5 | REACTOME INTERFERON GAMMA SIGNALING | Genes involved in Interferon gamma signaling |
0.0 | 0.2 | REACTOME ACTIVATION OF THE AP1 FAMILY OF TRANSCRIPTION FACTORS | Genes involved in Activation of the AP-1 family of transcription factors |
0.0 | 0.2 | REACTOME LYSOSOME VESICLE BIOGENESIS | Genes involved in Lysosome Vesicle Biogenesis |
0.0 | 0.1 | REACTOME DOWNREGULATION OF ERBB2 ERBB3 SIGNALING | Genes involved in Downregulation of ERBB2:ERBB3 signaling |
0.0 | 0.2 | REACTOME SIGNAL TRANSDUCTION BY L1 | Genes involved in Signal transduction by L1 |
0.0 | 0.1 | REACTOME TRANSFERRIN ENDOCYTOSIS AND RECYCLING | Genes involved in Transferrin endocytosis and recycling |
0.0 | 0.6 | REACTOME ION TRANSPORT BY P TYPE ATPASES | Genes involved in Ion transport by P-type ATPases |
0.0 | 0.2 | REACTOME AMINO ACID AND OLIGOPEPTIDE SLC TRANSPORTERS | Genes involved in Amino acid and oligopeptide SLC transporters |
0.0 | 0.8 | REACTOME O LINKED GLYCOSYLATION OF MUCINS | Genes involved in O-linked glycosylation of mucins |
0.0 | 0.3 | REACTOME ABCA TRANSPORTERS IN LIPID HOMEOSTASIS | Genes involved in ABCA transporters in lipid homeostasis |
0.0 | 0.1 | REACTOME SIGNAL ATTENUATION | Genes involved in Signal attenuation |
0.0 | 0.2 | REACTOME TRYPTOPHAN CATABOLISM | Genes involved in Tryptophan catabolism |
0.0 | 0.5 | REACTOME SMAD2 SMAD3 SMAD4 HETEROTRIMER REGULATES TRANSCRIPTION | Genes involved in SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription |
0.0 | 0.1 | REACTOME BILE SALT AND ORGANIC ANION SLC TRANSPORTERS | Genes involved in Bile salt and organic anion SLC transporters |
0.0 | 0.8 | REACTOME BIOLOGICAL OXIDATIONS | Genes involved in Biological oxidations |
0.0 | 0.8 | REACTOME RESPONSE TO ELEVATED PLATELET CYTOSOLIC CA2 | Genes involved in Response to elevated platelet cytosolic Ca2+ |
0.0 | 0.1 | REACTOME SYNTHESIS SECRETION AND DEACYLATION OF GHRELIN | Genes involved in Synthesis, Secretion, and Deacylation of Ghrelin |
0.0 | 0.1 | REACTOME REGULATED PROTEOLYSIS OF P75NTR | Genes involved in Regulated proteolysis of p75NTR |
0.0 | 0.1 | REACTOME PEPTIDE HORMONE BIOSYNTHESIS | Genes involved in Peptide hormone biosynthesis |
0.0 | 0.4 | REACTOME SIGNALING BY PDGF | Genes involved in Signaling by PDGF |